e10qsbza
 



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-QSB/ A

Amendment No. 1

Quarterly Report of Small Business Issuers under Section 13 or 15(d) of

the Securities Exchange Act of 1934 for the quarterly period ended October 31, 2002

Commission File No. 001-31552

Smith & Wesson Holding Corporation

(Exact name of registrant as specified in its charter)
     
Nevada
(State or other jurisdiction of incorporation or organization)
  87-0543688
(I.R.S. Employer Identification No.)
14500 North Northsight, Suite 116
Scottsdale, Arizona
(Address of principal executive offices)
  85260
(Zip Code)

Issuer’s telephone number, including area code:

(480) 949-9700


Number of shares outstanding of each of the issuer’s classes of common equity:

     
Class Outstanding as of January 7, 2004


Common stock, $0.001 par value
  30,761,380

The issuer is not using the Transitional Small Business Disclosure format.




 

EXPLANATORY NOTE

      This amendment on Form 10-QSB/ A (i) summarizes the impact and effect of the restatement of our previously filed fiscal year 2002 financial statements and the effects of that restatement for the quarters ended October 31, 2002 and 2001, (ii) identifies certain recent events and (iii) amends Items 1 and 2 of Part I, and Item 6 of Part II of the Quarterly Report of Smith & Wesson Holding Corporation (the “Company”) on Form 10-QSB previously filed for the quarter ended October 31, 2002. The restatement of our previously filed fiscal year 2002 financial statements is set forth in our Form 10-KSB for the fiscal year ended April 30, 2003, filed with the Securities and Exchange Commission on December 18, 2003.

      This amendment on Form 10-QSB/ A for the fiscal quarters ended October 31, 2002 and 2001 amends and restates only those items of the previously filed Form 10-QSB which have been affected by the restatement. In order to preserve the nature and character of the disclosures set forth in such items as originally filed, no attempt has been made in this amendment (i) to modify or update such disclosures except as required to reflect the effects of the restatement or (ii) to make revisions to the Notes to the Consolidated Financial Statements except for those which are required by or result from the effects of the restatement. For additional information regarding the restatement, see Note 9 to the Consolidated Financial Statements for Smith & Wesson Holding Corporation and Subsidiaries included in Part I — Item 1. No other information contained in the Company’s Form 10-QSB for the quarter ended October 31, 2002 has been updated or amended.

1


 

SMITH & WESSON HOLDING CORPORATION

TABLE OF CONTENTS

           
PART I:  FINANCIAL INFORMATION
       
The Restatement
    3  
Recent Developments
    10  
Item 1.  Financial Statements
       
Smith & Wesson Holding Corporation and Subsidiaries
       
 
Consolidated Balance Sheets at October 31, 2002; April 30, 2002, October 31, 2001 and April 30, 2001 (Saf-T-Hammer Corporation)
    11  
 
Consolidated Statements of Operations for the three and six months ended October 31, 2002 and 2001
    12  
 
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the three and six month periods ended October 31, 2002 and October 31, 2001
    13  
 
Consolidated Statements of Cash Flows for the three and six month periods ended October 31, 2002 and 2001
    14  
 
Notes to Consolidated Financial Statements
    15  
 
     The financial statements of Smith & Wesson Corp. are presented as of April 28, 2001 and for the thirteen day period ended May 11, 2001. They are presented for Smith & Wesson Corp. (SW) as predecessor to Smith & Wesson Holding Corporation. The Company has previously filed, on Form 8K/ A dated July 30, 2001 Balance Sheet of the predecessor SW as of April 28, 2001 from which the accompanying Balance Sheet has been derived. SW was acquired by the Company on May 11, 2001.
 
     The Company has previously filed, on Form 10-KSB dated December 18, 2003, the accompanying Consolidated Statements of Operations, Changes in Stockholder’s Equity and Cash Flows (the “Statements”). These Statements have been prepared without audit and have not been reviewed by independent accountants; however, the Company believes that all adjustments, which include only normal recurring adjustments necessary to fairly present SW’s results of operations, changes in stockholder’s equity and cash flows for the thirteen day period, have been included. All significant intercompany transactions have been eliminated.
 
Smith & Wesson Corp. and Subsidiary (the Predecessor)
       
 
Consolidated Balance Sheet at April 28, 2001
    47  
 
Consolidated Statements of Operations for the thirteen day period ended May 11, 2001
    48  
 
Consolidated Statements of Changes in Stockholder’s Equity for the thirteen day period ended May 11, 2001
    49  
 
Consolidated Statements of Cash Flows for the thirteen day period ended May 11, 2001
    50  
 
Notes to Consolidated Financial Statements
    51  
Item 2:  Management’s Discussion and Analysis or Plan of Operations
    62  
PART II:  OTHER INFORMATION
       
Item 6.  Exhibits And Reports On Form 8-K
    71  

2


 

PART I: FINANCIAL INFORMATION

The Restatement

 
Overview

      On March 17, 2003, the Company engaged PricewaterhouseCoopers LLP (PwC), as our independent public accountants to audit our financial statements for fiscal year 2003. On August 12, 2003, the Company engaged PwC to conduct a re-audit of our previously issued fiscal year 2002 financial statements. On December 18, 2003, we filed our Form 10-KSB for the fiscal year ended April 30, 2003, which included restated financial statements for the fiscal year ended April 30, 2002. These restatement changes affect the financial statements for each quarter in fiscal years 2003 and 2002. In this Form 10-QSB/ A, we are restating our previously filed financial statements for each of the three month periods and six month periods ended October 31, 2002 and October 31, 2001 to reflect adjustments required with respect to the acquisition balance sheet of Smith & Wesson Corp. (S&W) and other adjustments. These adjustments include, among other items:

  •  adjustments to net sales for product returns and freight invoiced to customers;
 
  •  adjustments to S&W’s product liability and environmental expenses;
 
  •  our accounting for non-cash interest and fees related to a note payable that we issued to finance a part of the acquisition of Smith & Wesson Corp.;
 
  •  adjustments to S&W’s income tax accounts; and
 
  •  adjustments to other accounts.
 
Discussion

      The restatement adjustments for fiscal year 2002 and the effects of those adjustments on the three and six months ended October 31, 2002 and 2001 are described within each subsection below:

 
Net Sales and Cost of Sales

      We have restated our fiscal year 2002 financial statements to increase net product sales by $2.8 million and increase cost of sales by $3.8 million. Included in the $2.8 million net product sales increase was $1.2 million to reverse a sales return recorded in error. The sales return related to a pre-acquisition sale by Smith & Wesson Corp., for which no reserve for returns had been established. Accordingly, upon return of the product, we now believe the returned goods should have been recorded as an increase in inventory of $1.2 million and as a reduction to acquired receivables of $1.2 million. As such, we restated our 2002 financial statements to increase net product sales by $1.2 million and increase cost of sales by $1.2 million. We also restated our fiscal year 2002 financial statements to increase net product sales by $1.6 million, increase marketing and selling expense by $0.7 million for cooperative advertising and distributor incentives, increase cost of goods sold by $0.8 million for the cost of freight and $0.1 million used to fund industry programs. These three costs had incorrectly been reported as reductions of sales. We also restated to increase cost of sales by $0.4 million for inventory and equipment write-offs, decrease cost of goods sold by $0.3 million for depreciation expense which was overstated as a result of errors in the S&W purchase accounting and to increase cost of goods sold by $1.6 million for adjustments to product liability reserves.

      The effect of these adjustments on our quarterly financial statements for the three months ended October 31, 2001 is to increase net product sales by $1.6 million which includes the $1.2 million sales return error referenced above and increase cost of sales by $1.1 million for the cost of sales related to the sales return and $0.3 million for the cost of freight. This is partially offset by a product liability adjustment of $0.2 million. We are also restating our financial statements for the three months ended October 31, 2002, to increase net product sales by $0.6 million, increase marketing and selling expense by $0.2 million for cooperative advertising and distributor incentives, $0.2 million of other income/expense, and increase cost of goods sold by $0.3 million for the cost of freight.

3


 

      The effect of these adjustments on the six months ended October 31, 2001 is to increase net product sales by $1.9 million, which includes the $1.2 million sales return referenced earlier as well as $0.6 million in freight, promotional and industry dues that had originally been reported as a reduction of sales and should have been charged to cost of sales and operating expenses. Cost of sales has been increased by $2.5 million which includes $1.0 million related to the sales return, $0.8 million relative to the product liability adjustment, $0.3 million in freight costs previously reported as a reduction to sales, and $0.4 million in for inventory and equipment write-offs. For the six months ended October 31, 2002 the effects of the restatement on net product sales was an increase of $1.4 million which, was the freight, promotional and industry dues that had originally been reported as a reduction of sales and should have been charged to cost of sales and operating expenses.

 
Product Liability and Environmental Expenses

      We have restated our fiscal year 2002 financial statements to record additional provisions of $2.5 million for environmental remediation and $1.6 million for product liability and accounted for such amounts as adjustments to the May 11, 2001 acquisition balance sheet of Smith & Wesson Corp. We now believe that under generally accepted accounting principles (GAAP) these amounts, aggregating $4.1 million, should have been expensed in 2002 rather than capitalized as increases to purchased assets under FAS 38, Accounting for Preacquisition Contingencies of Purchased Enterprises, which provides that adjustments of preacquisition contingencies after the end of the allocation period must be included in net income in the period the adjustment is determined. Accordingly, our fiscal year 2002 financial statements were restated to increase cost of goods sold by $1.6 million, to increase environmental expense by $2.5 million and to correspondingly reduce the amount of purchase price allocable to reduce purchased fixed assets and intangibles by $4.1 million.

      The effect of these adjustments for the three months ended October 31, 2001, is to decrease cost of goods sold by $0.2 million to adjust the product liability reserve. The effect of these adjustments on the six months ended October 31, 2001 was to increase cost of goods sold by $0.8 million for product liability and to increase environmental expense by $2.5 million.

 
Melby Financing; Interest Expense and Compensation Expense Adjustments

      We determined that there were errors in the accounting for a $5 million debt financing, known as the Melby financing, provided to us by Colton R. Melby to finance part of the acquisition of Smith & Wesson Corp. As a result of this loan and the related stock warrants issued, we originally recorded approximately $5,008,500 in expense consisting of $5,000,000 in interest expense, $6,000 in depreciation expense and $2,500 in office supplies expense in fiscal year 2002. We have now determined that under GAAP we should have recorded aggregate expense of $4,541,500 consisting of $2,567,166 in interest expense for amortization of debt discount related to the warrants; $827,414 in interest expense for amortization of debt issue costs arising from the consideration paid to the parties who assisted in arranging the financing (the finders); a loss on early extinguishment of the note payable of $294,420 charged to interest expense; interest expense of $185,000 resulting from settlement of the finders’ liability and compensation expense of $667,500 to a finder related to his employment by us. The net result of these transactions is that the previously reported pre-tax loss for the fiscal year ended April 30, 2002 was overstated by $467,000. Our fiscal year 2002 financial statements were restated accordingly, to decrease interest expense by $1,126,000, decrease depreciation expense by $6,000, decrease supplies expense by $2,500 and increase general and administrative expense by $667,500 for compensation expense.

      The following discussion provides additional background on the Melby financing. On May 6, 2001, we sold to Mr. Melby a $5 million nonconvertible note due May 12, 2002 and warrants, known as the Melby warrants, to acquire shares of our common stock. At the time of this financing transaction, Mr. Melby had no relationship with us. He became a director of the Company in May 2001, served as our Executive Vice President from May 2002 to September 2002 and served as our President and Chief Operating Officer from September 2002 to December 2003. Under the terms of the Melby financing, we also issued additional warrants, known as the Melby affiliate warrants, to Mr. Melby’s two brothers and one of his associates. Shortly after the issue date, Mr. Melby’s brothers exercised their Melby affiliate warrants. The Melby affiliate warrants issued to Mr. Melby’s associate expired unexercised.

4


 

      We initially valued the Melby warrants and the Melby affiliate warrants and recorded a debt discount of $5,000,000 completely offsetting the Melby Note of the same amount. We now believe that under GAAP the $5.0 million financing proceeds should have been allocated among the debt and the Melby warrants and Melby affiliate warrants on a relative fair value basis. Based on their relative values, we have determined that, of the $5.0 million financing proceeds, $2,245,000 should have been allocated to the debt and $2,755,000 should have been allocated to equity for the warrants. As a result of the warrant discount, interest expense for the fiscal year ended April 30, 2002 should have been $2,755,000, comprising $2,567,166 amortized to interest expense over the period from the May 2001 debt issue date through the debt extinguishment date and an early extinguishment loss of $187,834 on the debt extinguishment date. The $5.0 million of debt was redeemed in an early extinguishment on March 28, 2002 for $5 million of consideration consisting of $2,837,000 in cash and $2,162,200 in common stock valued at the March 28, 2002 extinguishment date. Mr. Melby used the $2,837,800 of cash from the extinguishment to exercise his warrants. On the debt extinguishment date, an extinguishment loss of $294,420, including the remaining unamortized debt issue costs of $106,586 and the unamortized debt discount of $187,834, should have been recognized.

      For the three and six months ended October 31, 2001, we should have recorded interest expense of $756,145 and $1,768,809 respectively, relating to the Melby Note, the Melby Warrants, and the Melby Affiliate Warrants compared to interest expense previously recorded of $1.6 million and $3.6 million, respectively.

      In connection with the Melby financing, on May 11, 2001 we also issued warrants, known as the finders’ warrants, to the two finders retained to locate the Melby financing. These warrants had a fair value of $434,000. In addition to the finders’ warrants, each finder was also entitled to receive a $250,000 cash fee. On May 6, 2001, we advised the finders that they would be paid this fee in approximately 90 days. We now believe that, under GAAP, we should have recorded debt issue costs of $934,000 together with a corresponding liability of $500,000 and $434,000 of paid in capital for the finders’ warrants. In addition, we should have recorded amortization expense of $827,414 in fiscal year 2002 related to the debt issue costs and we should have written off the remaining unamortized debt issue costs of $106,586 on the debt extinguishment date.

      For the three and six months ended October 31, 2001, we should have recorded interest expense of $236,881 and $480,937 respectively, relating to the finders’ warrants.

      On September 24, 2001, we issued 500,000 shares of common stock to one of the finders to settle the $250,000 liability to him. In addition, on August 9, 2001, we paid $62,500 cash to the other finder, Mr. Corey Lambrecht, which reduced our liability to him from $250,000 to $187,500. On April 1, 2002, Mr. Lambrecht became our Vice President of Licensing. On April 30, 2002, we issued 375,000 shares to him. He has served as our Executive Vice President since September 2002. We had previously recorded the issuance of 875,000 shares of common stock as of May 6, 2001 as a credit to paid in capital for $437,500 or $0.50 per share, although these shares were unissued as of May 6, 2001. We now believe that under GAAP we should have recorded an extinguishment loss of $185,000 in September 2001 based upon the 500,000 shares issued to the first finder on September 24, 2001 (500,000 shares valued at $0.87 as of the date of issuance less the $250,000 restated liability as of May 6, 2001). Based upon the 375,000 shares issued to Mr. Lambrecht on April 30, 2002, our restatement includes a compensation expense of $667,500 in April 2002 (375,000 shares valued at $2.28 on the date of issuance less the $187,500 remaining restated liability as of April 2002).

      Because the finders’ fees were determined to be settled in a fixed number of shares of stock, we now believe that we should have recorded the excess of the market value of the stock to be issued over the original amount of the obligation as additional expense for the three months ended October 31, 2001. The liability to one of the finders was settled during the three months ended October 31, 2001 and $60,000 was recognized as interest expense. The difference between the market value and the initial value of the 500,000 shares due to Mr. Lambrecht for the three months ended October 31, 2001 results in recognizing a decrease in compensation expense of $12,500.

      For the six months ended October 31, 2001, the Company has recorded $185,000 in interest expense as an extinguishment of debt relative to the difference between the market value and the initial value of the 500,000 shares issued to one of the finders. The Company has also recorded $112,500 as compensation

5


 

expense for the six months ended October 31, 2001 for the difference between the market value and the initial value of the 375,000 shares due to Mr. Lambrecht.
 
Adjustments for Income Tax Accounting Error Corrections

      Our acquisition of Smith & Wesson Corp. was a stock transaction for which no election was made under Internal Revenue Code Section 338 to treat the transaction as an asset purchase for income tax purposes. Therefore, while a new basis of accounting was established for financial reporting purposes, all historical tax bases carried over, resulting in substantial deferred tax temporary differences at the time of the acquisition.

      On the opening balance sheet at the May 11, 2001 acquisition date of Smith & Wesson Corp., we reported a $10.5 million deferred tax liability. In the fourth quarter of fiscal year 2002, we subsequently determined that this $10.5 million deferred tax liability was an error on the opening balance sheet requiring correction under GAAP. The net deferred tax balance on the opening balance sheet as of May 11, 2001 should have reflected deferred tax liabilities and assets as set forth in the following table.

Deferred Tax Liabilities and Assets Reflected in the Net Deferred Tax Balance

on the Restated Opening Balance Sheet as of May 11, 2001
                           
Previously Reported Restated as of
as of May 11, 2001 Change May 11, 2001



Deferred Tax Liabilities
  $ (10,547,329 )   $ 3,134,816     $ (7,412,513 )
Deferred Tax Assets
    8,000,000       9,648,372       17,648,372  
     
     
     
 
Net Deferred Tax Asset/(Liability) before Valuation Allowance
    (2,547,329 )     12,783,188       10,235,859  
 
Less: Valuation Allowance
    (8,000,000 )     (2,235,859 )     (10,235,859 )
     
     
     
 
Net Deferred Tax Asset/(Liability) at Opening Balance Sheet date
  $ (10,547,329 )   $ 10,547,329     $ 0  
     
     
     
 

      In our previously filed annual report on Form 10-KSB for the fiscal year ended April 30, 2002, we recorded adjustments in the fourth quarter of fiscal year 2002 to correct these errors in the opening balance sheet for deferred tax balances by decreasing net deferred tax liabilities by $10.5 million and decreasing fixed assets and intangible assets by $10.5 million. Although these fourth quarter corrections had no impact on our previously reported tax provision for fiscal year 2002, depreciation and amortization expense for 2002 are overstated as a result of recording the correction in the fourth quarter rather than as of May 11, 2001. We now believe we should have had a net deferred tax asset of $10.2 million with a corresponding valuation allowance of $10.2 million at May 11, 2001 to total to a net zero balance for deferred taxes on the opening balance sheet. This finding has a direct impact on each of the first three quarters of fiscal year 2002 as deferred tax benefits were recorded in each of these quarters.

      The impact for the quarter ended October 31, 2001 was to increase income tax expense by $1.7 million to eliminate the previously reported benefit from income tax of $1.7 million and record income tax expense of $17,649.

      For the six months ended October 31, 2001, the impact was to increase income tax expense by $1.9 million to eliminate the previously reported benefit from income tax of $1.8 million and record income tax expense of $35,298.

 
Other Items

      We also restated our fiscal year 2002 financial statements to record the following adjustments that resulted in the changes set forth in the table above:

  •  Property, Plant and Equipment. — We acquired Smith & Wesson Corp. in a bargain purchase that resulted in writing down long-lived assets below fair value, resulting in decreasing fixed assets to a

6


 

  financial statement basis that is less than the net tax basis, which creates a deferred tax asset. This temporary difference should have resulted in a deferred tax asset of approximately $4.8 million. However, we incorrectly recorded a $2.0 million deferred tax liability related to fixed assets which was included in the $10.5 million deferred tax liability. This error was discovered and corrected in the fourth quarter of fiscal year 2002 but should have been corrected effective May 11, 2001. The adjustment in the fourth quarter of fiscal year 2002 reduced deferred tax liabilities by $2.0 million, increased deferred tax assets by $4.8 million and reduced fixed assets and intangible assets by $6.8 million.
 
  •  Trademark. — The trademark is being amortized over a 20-year period for financial statement purposes, and the historical tax basis of the trademark is zero, which results in a deferred tax liability. A deferred tax liability of $2,640,000 relating to the trademark was previously recorded at the opening balance sheet as part of the $10.5 million deferred tax liability. However, Smith & Wesson Corp. had sufficient deferred tax assets to offset this liability, which reverses over a foreseeable time frame (20 years). A full valuation allowance of $8.0 million against deferred tax assets was previously recorded in the opening balance sheet, thus resulting in recognition of only deferred tax liabilities on the balance sheet. In the fourth quarter of fiscal year 2002, we determined that this deferred tax liability must, under GAAP, be considered as a source of future taxable income available to offset deferred tax assets at May 11, 2001. Therefore, at May 11, 2001, no valuation allowance should have been recognized to the extent deferred tax assets will be utilized by this reversing deferred tax liability, meaning that the valuation allowance at opening balance sheet was overstated. This overstatement was corrected in the fourth quarter of 2002.
 
  •  LIFO Reserve. — The last in, first out (LIFO) reserve book versus tax difference was created primarily as the result of purchase accounting adjustments made to inventory. Smith & Wesson Corp. had historically valued its financial statement and tax inventory under the LIFO accounting method. The inventory acquired in the May 11, 2001 acquisition was recorded at fair value. Therefore, for book purposes the LIFO reserve was zero at May 11, 2001. However, the inventory basis and related LIFO reserve was unchanged for tax purposes. Therefore, there was a LIFO reserve for tax purposes only of approximately $14.7 million, creating a temporary difference. We now believe that the use of tax planning strategies available with respect to the LIFO reserve were not appropriately considered for purposes of determining the valuation allowance for the opening balance sheet. This error at opening balance sheet was discovered and corrected in the fourth quarter of the fiscal year 2002 based on tax planning strategies which would allow us to recognize the LIFO temporary difference as a source of future taxable income for purposes of determining the deferred tax asset valuation allowance.
 
  •  Deferred Taxes. — Our Form 10-KSB for the fiscal year ended April 30, 2002 as originally filed also reflects adjustments made in the fourth quarter of fiscal year 2002 to adjust deferred taxes to reverse approximately $2 million of tax benefits recorded over the prior three fiscal quarters.

      We are also filing an amended income tax return with the Internal Revenue Service for the fiscal year ended April 30, 2002. The amended return increases our net operating loss carryforward. As a result, our deferred tax asset relating to net operating losses was also understated in the April 30, 2002 tax provision. Since there is a full valuation allowance against this asset, there is no net balance sheet effect at April 30, 2002 or income statement impact on the financial statements for fiscal year 2002 other than a change to the footnote disclosures.

 
Adjustments to General and Administrative Expenses

      We also restated our fiscal year 2002 financial statements to record $1,232,634 of additional costs and expenses related to reserves for self-insured medical costs, unemployment insurance, workers’ compensation reserves, and legal services that were previously accounted for as purchase adjustments to the May 11, 2001 acquisition balance sheet of Smith & Wesson Corp. and which we now believe under GAAP should have been

7


 

expensed in fiscal year 2002. These adjustments increased our previously reported pre-tax loss for fiscal year 2002. A summary of the items comprising the $1,232,634 is presented below:

Adjustments to Expense in Fiscal Year 2002 for Items Previously Capitalized

         
Increase in medical self insurance reserves and unemployment reserves after the acquisition date
  $ 374,634  
Increase in workers’ compensation reserve and cost of Directors and Officers insurance required under Massachusetts law as a result of the acquisition of Smith & Wesson Corp.
    175,000  
Accounting and legal costs
    683,000  
     
 
Total
  $ 1,232,634  
     
 

      For the three months ended October 31, 2001, we should have recorded a total of $240,000. These expenses are comprised entirely of additional accounting and legal costs.

      For the six months ended October 31, 2001, we should have recorded $450,000 of additional expense consisting of accounting and legal costs of $275,000 and the workers compensation/ Directors and Officers insurance expense of $175,000.

 
Other Income/Expense

      We restated our fiscal year 2002 financial statements to increase other expense by $47,200 which includes a loss on extinguishment of debt $187,834 offset by other income including approximately $61,000 of income from the Walther U.S.A. joint venture.

      For the three months ended October 31, 2001, we should have recorded other income of $331,678 substantially comprised of $55,950 for other income related to the Walther joint venture and interest income of $223,750.

      For the six months ended October 31, 2001, we should have recorded other expense of $21,089.

 
Summary of Restatement Adjustments

      The aggregate impact to our fiscal year statement of operations of the adjustments described above is to increase our previously reported 2002 pre-tax net loss by $5.3 million. The following table summarizes the statement of operations impact of these adjustments on our net loss for the period indicated.

Restatement and Adjustment Impact on Net Income (Loss)

                         
Fiscal Year Ended April 30, 2002

As Previously
Reported Net Change Restated



(In millions, except per share data)
Net Product Sales
  $ 76.5     $ 2.8     $ 79.3  
Cost of Sales
    56.9       (3.8 )     60.7  
License income, net
    1.2       0.0       1.2  
Expenses, including operating expense and other income and expense
    17.7       (5.6 )     23.3  
Interest Expense, net
    8.5       1.3       7.2  
Income Taxes
    0.1       0.0       0.1  
Net income (loss) (increase) decrease
  $ (5.5 )   $ (5.3 )   $ (10.8 )
Earnings per share Basic
  $ (0.27 )   $ (0.25 )   $ (0.52 )
Diluted
  $ (0.27 )   $ (0.25 )   $ (0.52 )

8


 

      The aggregate impact of the fiscal year 2002 restatement on our financial statements for the three months ended October 31, 2001, is to increase our previously reported net loss by $937,373 to $1,363,377. Additionally, the restatement had minor effects on our financial statements for the three months ended October 31, 2002 resulting in a decrease of our net income for that period of $114,746 to $136,862. The following table summarizes the statement of operations impact of these adjustments on our net loss for each of the periods indicated.

Restatement and Adjustment Impact on Net Income (Loss)

                                                 
Three Months Ended Three Months Ended
October 31, 2002 October 31, 2001


As As
Previously Net Previously Net
Reported Change Restated Reported Change Restated






(In millions, except per share data)
Net Product Sales
  $ 23.5     $ 0.6     $ 24.1     $ 19.9     $ 1.6     $ 21.5  
Cost of Sales
    16.6       0.3       16.9       15.8       1.2       17.0  
License income, net
    0.3       0.0       0.3       0.3       0.1       0.4  
Expenses, including operating expense and other income and expense
    6.3       0.4       6.7       4.1       0.3       4.4  
Interest Expense
    0.6       0.1       0.7       2.4       (0.5 )     1.9  
Income Taxes
    0.0       0.0       0.0       (1.7 )     1.7       0.0  
Net Income (loss) (increase) decrease
    0.3       (0.2 )     0.1       (0.4 )     (1.0 )     (1.4 )
 
Earnings per share
                                               
Basic
    .01       (.01 )     0.0       (.02 )     (.05 )     (.07 )
Diluted
    .01       (.01 )     0.0       (.02 )     (.05 )     (.07 )
                                                 
Six Months Ended Six Months Ended
October 31, 2002 October 31, 2001


As As
Previously Net Previously Net
Reported Change Restated Reported Change Restated






(In millions, except per share data)
Net Product Sales
  $ 44.0     $ 1.4     $ 45.4     $ 31.1     $ 1.9     $ 33.0  
Cost of Sales
    31.9       0.4       32.3       26.7       2.5       29.1  
License income, net
    0.6       0.0       0.6       0.6       0.0       0.6  
Expenses, including operating expense and other income and expense
    11.1       0.8       11.9       7.9       3.1       11.0  
Interest Expense
    1.7       0.1       1.8       5.5       (1.1 )     4.5  
Income Taxes
    0.0       0.0       0.0       (1.8 )     1.9       0.0  
Net (loss) (increase) decrease*
    0.0 *     0.0 *     0.0       (6.5 )*     (4.5 )     (11.0 )
 
Earnings per share
                                               
Basic
    0.0       0.0       0.0       (.35 )     (.22 )     (.57 )
Diluted
    0.0       0.0       0.0       (.35 )     (.22 )     (.57 )

(*)  Do not add due to rounding
 
Change from LIFO to FIFO Method

      Our annual report on Form 10-KSB for the fiscal year ended April 30, 2002 incorrectly disclosed that we adopted the first in, first out (FIFO) method of inventory valuation for Smith & Wesson Corp. following our

9


 

acquisition of Smith & Wesson Corp. on May 11, 2001. We did not adopt the FIFO method of inventory valuation for S&W until the fourth quarter of fiscal year 2002. Our disclosure in our quarterly reports filed on Form 10-QSB for the quarters ended October 31, 2001 and January 31, 2002 correctly disclosed that for these quarters, inventory was valued using the last in, first out (LIFO) method. However, following the acquisition of S&W on May 11, 2001, we failed to record adjustments during each of the first three quarters of fiscal year 2002 to reflect S&W’s inventory in accordance with the LIFO method of inventory accounting. The result was that the cost of sales amounts reported in our previously filed 2002 quarterly financial statements were equivalent to a FIFO basis. S&W changed to the FIFO method of accounting during the fourth quarter of fiscal year 2002.

      Under GAAP, a change to the FIFO method would ordinarily require that the financial statements of all prior periods presented be restated to reflect results under the newly adopted FIFO accounting method. However, since our quarterly results initially reported for the three months ended October 31, 2001 reflect the FIFO basis of accounting for inventory (even though we disclosed that our inventory was accounted for on a LIFO basis) we do not believe we need to amend our previously reported results for this matter.

 
Amendments to Prior Filings

      On December 18, 2003, we filed our annual report for the year ended April 30, 2003 on Form 10-KSB. This annual report includes our restated consolidated financial statements for the year ended April 30, 2002.

      This quarterly report on Form 10-QSB/ A includes our restated consolidated financial statements for the quarters ended October 31, 2002 and 2001. We have not amended our 2001 previously-filed report on Form 10-QSB. We expect to amend our other 2002 and 2003 quarterly reports previously filed on Form 10-QSB by filing amendments with the SEC early in calendar year 2004.

      Accordingly, the consolidated financial statements and related consolidated financial information contained in the annual report for fiscal year 2002 and quarterly reports for fiscal years 2002 and 2003 should no longer be relied upon.

 
Recent Developments
 
American Stock Exchange Listing Status

      On September 11, 2003, we received notice from the American Stock Exchange staff indicating that we are not in compliance with the American Stock Exchange’s continued listing standards due to our inability to file with the SEC in a timely manner our Form 10-KSB for the fiscal year ended April 30, 2003, as required under the rules of the American Stock Exchange. On September 25, 2003, we submitted a plan of compliance to the American Stock Exchange. The staff of the American Stock Exchange accepted our plan on October 17, 2003, and it granted us an extension of time to regain compliance with the continued listing standards.

      Because we were not able to file our Form 10-KSB by October 24, 2003, the date specified in our original plan to the Exchange, we requested the opportunity to submit a revised plan to the staff of the American Stock Exchange. Under this revised plan submitted to and accepted by the Exchange on November 25, 2003 and as further amended on December 12, 2003 and on December 31, 2003, we are filing our quarterly reports for the first and second quarters of fiscal year 2004 and amending our quarterly reports for the first and second quarters of fiscal year 2003 as of the date of this filing, January 9, 2004. We will continue to be subject to periodic review by the staff of the American Stock Exchange. If we fail to make progress consistent with the revised plan or fail to regain compliance with the continued listing standards, we may be delisted from the American Stock Exchange.

 
SEC Investigation

      The SEC is conducting an investigation to determine whether there have been violations of the federal securities laws in connection with matters relating to the restatement of our consolidated financial statements for fiscal year 2002. We continue to be in discussions with the SEC and intend to continue to fully cooperate with the SEC.

10


 

Item 1: Financial Statements

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED BALANCE SHEETS
                                     
Restated Restated Saf-T-
(Note 9) (Note 9) Hammer
October 31, October 31, Corporation
2002 April 30, 2002 2001 April 30, 2001




Unaudited Unaudited
ASSETS
Current assets:
                               
 
Cash and cash equivalents
  $ 11,840,478     $ 20,012,491     $ 27,915,853     $ 69,110  
 
Marketable securities
    1,538,890       1,003,159              
 
Accounts receivable, net of allowance for doubtful accounts of $114,076 on October 31,2002, $100,566 on April 30, 2002, $94,812 on October 31, 2001, and $0 on April 30, 2001
    12,425,214       12,099,436       10,905,366       3,904  
 
Inventories
    18,250,430       19,354,781       18,721,008       21,780  
 
Other current assets
    3,465,563       1,447,143       3,213,239       194,832  
 
Income tax receivable
    188,566       211,803              
 
Due from Tomkins Corporation
                464,500        
 
Due from Walther USA, LLC
                458,374        
     
     
     
     
 
   
Total current assets
    47,709,141       54,128,813       61,678,340       289,626  
     
     
     
     
 
Property, plant and equipment, net
    5,524,025       4,199,207       2,597,930       31,752  
Intangibles, net
    962,081       986,408       765,433        
Collateralized cash deposits
    22,209,695       21,227,025       6,228,425        
Other assets
    15,996,000       15,903,400       15,491,700        
     
     
     
     
 
    $ 92,400,942     $ 96,444,853     $ 86,761,828     $ 321,378  
     
     
     
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
                               
 
Accounts payable
  $ 5,024,550     $ 6,955,136     $ 5,752,229     $ 693,978  
 
Accrued expenses
    7,348,734       7,999,450       6,795,206        
 
Accrued payroll
    2,550,271       3,135,117       2,351,369        
 
Accrued taxes other than income
    1,632,967       1,755,859       1,518,627        
 
Accrued profit sharing
    494,137       819,838              
 
Accrued income taxes
                21,513        
 
Finders liability
                300,000        
 
Deferred revenue
    1,597,562       1,597,674       1,622,526        
 
Note payable, related party net of debt issue costs of $1,439,254 as of October 31, 2001
          357,425       4,158,171       597,425  
 
Note payable, Tomkins
                10,000,000        
 
Note payable, unrelated party net of debt issue costs of $114,000
                      386,000  
 
Due to Walther USA, LLC, net
    204,216       529,353              
     
     
     
     
 
   
Total current liabilities
    18,852,437       23,149,852       32,519,641       1,677,403  
     
     
     
     
 
Notes payable
    45,000,000       45,000,000       30,000,000        
     
     
     
     
 
Other non-current liabilities
    29,590,002       29,449,775       32,295,193        
     
     
     
     
 
Commitments and contingencies (Note 6)
                       
Stockholders’ equity (deficit):
                               
 
Common stock, $.001 par value, 100 million shares authorized 29,750,730 and 19,501,689 shares issued and outstanding on October 31, 2002 and 2001, respectively, and 29,683,613 and 18,131,355 shares issued and outstanding on April 30, 2002 and 2001, respectively
    29,750       29,683       19,502       18,131  
 
Additional paid-in capital
    15,827,460       15,751,515       9,177,606       4,786,469  
 
Accumulated (deficit)
    (16,913,880 )     (16,938,840 )     (17,250,114 )     (6,160,625 )
 
Accumulated other comprehensive income
    15,173       2,868              
     
     
     
     
 
   
Total stockholders’ equity (deficit)
    (1,041,497 )     (1,154,774 )     (8,053,006 )     (1,356,025 )
     
     
     
     
 
    $ 92,400,942     $ 96,444,853     $ 86,761,828     $ 321,378  
     
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

11


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENTS OF OPERATIONS
AND OTHER COMPREHENSIVE INCOME (LOSS)
                                     
For the Three Months Ended: For the Six Months Ended:


Restated (Note 9) Restated (Note 9) Restated (Note 9) Restated (Note 9)
October 31, 2002 October 31, 2001 October 31, 2002 October 31, 2001




Net product sales
  $ 24,074,731     $ 21,546,885     $ 45,372,079     $ 33,024,636  
License revenue
    416,128       379,689       711,876       638,506  
Cost of goods sold
    16,913,777       16,967,628       32,315,932       29,157,828  
Cost of services
    40,894       0       63,327       17,593  
     
     
     
     
 
Gross profit
    7,536,188       4,958,946       13,704,696       4,487,721  
     
     
     
     
 
Operating expenses:
                               
 
Research and development, net
    318,717       141,897       520,274       289,620  
 
Selling and marketing
    2,710,086       2,204,676       5,318,145       3,808,235  
 
General and administrative
    3,663,186       2,155,065       6,436,370       4,887,739  
 
Environmental expense
                      2,500,000  
     
     
     
     
 
   
Total operating expenses
    6,691,989       4,501,638       12,274,789       11,485,594  
     
     
     
     
 
Income/(loss) from operations
    844,199       457,308       1,429,907       (6,997,873 )
     
     
     
     
 
Other income/(expense):
                               
 
Other income/(expense)
    27,308       107,928       54,059       (21,089 )
 
Interest income
    174,790       223,750       362,563       472,371  
 
Interest expense
    (900,081 )     (2,134,714 )     (1,796,894 )     (4,507,600 )
     
     
     
     
 
      (697,983 )     (1,803,036 )     (1,380,272 )     (4,056,318 )
     
     
     
     
 
Income (loss) before income taxes
    146,216       (1,345,728 )     49,635       (11,054,191 )
Income tax expense
    9,354       17,649       24,675       35,298  
     
     
     
     
 
Net income (loss)
  $ 136,862     $ (1,363,377 )   $ 24,960     $ (11,089,489 )
Other comprehensive income:
                               
 
Unrealized gain on marketable securities net of income tax of $5,967 and $5,967, respectively
    3,169             12,305        
     
     
     
     
 
Comprehensive income (loss)
  $ 140,031     $ (1,363,377 )   $ 37,265     $ (11,089,489 )
     
     
     
     
 
Weighted average number of common equivalent shares outstanding, basic
    29,705,499       20,131,178       29,694,556       19,613,603  
     
     
     
     
 
Net income/(loss) per share, basic
  $ 0.00     $ (0.07 )   $ 0.00     $ (0.57 )
     
     
     
     
 
Weighted average number of common equivalent shares outstanding, diluted
    33,725,708       20,131,178       33,705,580       19,613,603  
     
     
     
     
 
Net income/(loss) per share, diluted
  $ 0.00     $ (0.07 )   $ 0.00     $ (0.57 )
     
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

12


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENTS OF CHANGES IN
STOCKHOLDERS’ EQUITY (DEFICIT)
For the Six Months Ended October 31, 2002 and 2001 (restated Note 9)
                                                 
Accumulated Total
Common Stock Additional Other Stockholders’

Paid-in Accumulated Comprehensive Equity
Shares Amount Capital Deficit Income (Deficit)






Balance at April 30, 2001
    18,131,355     $ 18,131     $ 4,786,469     $ (6,160,625 )           $ (1,356,025 )
Issuance of warrants for services related to debt financing
                    3,189,000                       3,189,000  
Common stock issued to settle liabilities
    500,000       500       434,500                       435,000  
Exercise of warrants
    750,000       750       599,250                       600,000  
Issuance of common stock for services
    120,334       121       168,387                       168,508  
Net (loss) for the six months ended October 31, 2001
                            (11,089,489 )             (11,089,489 )
Other comprehensive income
                                           
     
     
     
     
     
     
 
Balance at October 31, 2001
    19,501,689     $ 19,502     $ 9,177,606     $ (17,250,114 )   $     $ (8,053,006 )
     
     
     
     
     
     
 
                                                 
Accumulated Total
Common Stock Additional Other Stockholders’

Paid-in Accumulated Comprehensive Equity
Shares Amount Capital Deficit Income (Deficit)






Balance at April 30, 2002
    29,683,613     $ 29,683     $ 15,751,515     $ (16,938,840 )   $ 2,868     $ (1,154,774 )
Shares issued under ESPP on October 1, 2002
    67,117       67       75,945                       76,012  
Net income for the six months ended October 31, 2002
                            24,960               24,960  
Other comprehensive income
                                    12,305       12,305  
     
     
     
     
     
     
 
Balance at October 31, 2002
    29,750,730     $ 29,750     $ 15,827,460     $ (16,913,880 )   $ 15,173     $ (1,041,497 )
     
     
     
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

13


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 

CONSOLIDATED UNAUDITED STATEMENTS OF CASH FLOWS

For the Six Months Ended:
                       
Restated Restated
(Note 9) (Note 9)
October 31, 2002 October 31, 2001


Cash flows provided by (used for) provided by operating activities:
               
 
Net income (loss)
  $ 24,960     $ (11,089,489 )
 
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
               
   
Amortization and depreciation
    413,250       168,055  
   
Gain on sale of automobile
    (2,870 )      
   
Provision for losses on accounts receivable
    15,000       13,950  
   
Provision for excess and obsolete inventory
    197,644       1,634,472  
   
Stock compensation for services
          168,508  
   
Debt discount amortized to interest expense
          1,882,809  
   
Amortization of debt issue costs to interest expense
          480,937  
   
Loss on Finder’s liability settled in stock
          185,000  
   
Compensation expense settled in stock
          112,500  
 
Changes in operating assets and liabilities
               
 
(Increase) decrease in assets:
               
   
Accounts receivable
    (340,778 )     (3,181,895 )
   
Inventories
    906,707       3,925,158  
   
Due from Tomkins
          7,235,000  
   
Other current assets
    (2,018,420 )     (1,885,361 )
   
Income tax receivable
    23,237        
   
Due from Walther USA, LLC, net
          190,610  
   
Other assets
    (92,600 )     (1,305,168 )
 
Increase (decrease) in liabilities:
               
   
Accounts payable
    (1,930,586 )     1,925,934  
   
Accrued payroll
    (584,846 )     (1,470,480 )
   
Accrued profit sharing
    (325,701 )     0  
   
Accrued taxes other than income
    (122,892 )     146,677  
   
Accrued income taxes payable
          21,513  
   
Finders liability
          300,000  
   
Accrued expenses
    (650,716 )     (6,131,127 )
   
Other non-current liabilities
    140,227       8,340,007  
   
Deferred revenue
    (112 )     9,819  
   
Due to Walther USA, LLC, net
    (325,137 )      
     
     
 
     
Net cash (used for) provided by operating activities
    (4,673,633 )     1,677,429  
     
     
 
Cash flows (used for) provided by investing activities:
               
 
Net cash and cash equivalents acquired from business combination
          48,598,168  
 
Cash portion of business acquisition
          (5,000,000 )
 
Payments to acquire marketable securities
    (523,426 )      
 
Additions to collateralized cash deposits
    (982,670 )     (1,078,425 )
 
Payments to secure financing
          (362,500 )
 
Payments to acquire patents
    (67,102 )      
 
Payments to acquire property and equipment
    (1,643,769 )     (1,087,929 )
     
     
 
     
Net cash (used for) provided by investing activities
    (3,216,967 )     41,069,314  
     
     
 
Cash flows (used for) financing activities:
               
 
Payment on notes payable, Tomkins
          (20,000,000 )
 
Proceeds from note payable, related parties
          5,000,000  
 
Payments on loans and notes payable, related parties
    (357,425 )     (500,000 )
 
Proceeds from sale of common stock
    76,012        
 
Proceeds from exercise of warrants to acquire common stock
          600,000  
     
     
 
     
Net cash used for financing activities
    (281,413 )     (14,900,000 )
     
     
 
Net (decrease) increase in cash and cash equivalents
    (8,172,013 )     27,846,743  
Cash and cash equivalents, beginning of year
    20,012,491       69,110  
     
     
 
Cash and cash equivalents, end of period
  $ 11,840,478     $ 27,915,853  
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

14


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

CONSOLIDATED FINANCIAL STATEMENTS
For the Three and Six Months Ended October 31, 2002 and 2001

Notes to Consolidated Financial Statements

(1) Basis of Presentation:

      The restated consolidated balances sheets as of October 31, 2002 and 2001, the restated consolidated statements of operations and changes in stockholders’ equity (deficit) for the three and six months ended October 31, 2002 and 2001 and the cash flow statements for the six months ended October 31, 2002 and 2001, have been prepared by the Company, without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to fairly present the financial position, results of operations changes in stockholder’s equity (deficit) and cash flows at October 31, 2002 and 2001 and for the periods presented, have been included, All significant intercompany transactions have been eliminated.

      Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. These consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s April 30, 2003 Annual Report to Shareholders on Form 10-KSB.

(2) Organization:

     Organization

      Smith & Wesson Holding Corporation, (the “Company”) was incorporated on June 17, 1991 in the State of Nevada as De Oro Mines, Inc. The Company’s original Articles of Incorporation provided for 1,000,000 shares of common stock with a par value of $0.01 per share. From its inception, De Oro Mines, Inc. was a development stage company primarily engaged in the business of developing mining properties. During 1992, De Oro transferred its remaining assets, settled its liabilities and remained dormant until 1996.

      On August 15, 1996, the shareholders of the Company authorized the recapitalization of the Company and the amendment of its Articles of Incorporation to allow the corporation to issue up to 100,000,000 shares of a single class of common stock with a par value of $0.001 per share. The amended Articles were duly adopted as stated and were filed on October 16, 1996 with the State of Nevada.

      Effective October 20, 1998, the Company acquired the assets of Saf-T-Hammer, Inc. and changed its name from De Oro Mines, Inc. to Saf-T-Hammer Corporation. The acquisition was accounted for under the purchase method. Prior to this agreement becoming effective, the Company had a total of 532,788 shares of common stock issued and outstanding. Pursuant to the Asset Acquisition Agreement, the Company issued 1,331,250 shares of common stock to Saf-T-Hammer, Inc., which then resulted in a total of 1,864,038 shares of common stock being issued and outstanding.

      On May 11, 2001, the Company purchased all of the outstanding stock of Smith & Wesson Corp. for $15,000,000 from Tomkins Corporation and accordingly the operations of Smith Wesson Corp. are included in these financial statements from the date of acquisition (See Note 3 “Acquisition of Smith & Wesson Corp.”). Smith & Wesson Corp. was incorporated under the laws of the State of Delaware on January 13, 1987. Smith & Wesson Corp. has been in business since 1852, during which period ownership has changed on a few occasions. Prior to incorporation on January 13, 1987, Smith & Wesson Corp. operated as a division of Lear Siegler. On June 9, 1987, Tomkins Corporation (“Tomkins”), a company organized under the laws of the State of Delaware, acquired all the outstanding stock of the Company.

     Name Change

      At a special meeting held February 14, 2002, and at the recommendation of the Board of Directors, the Company’s shareholders approved a change of the Company’s name to “Smith & Wesson Holding Corporation.”

15


 

(3) Acquisition of Smith & Wesson Corp.:

 
The Acquisition

      Pursuant to a Stock Purchase Agreement (the “Acquisition Agreement”) dated as of May 11, 2001 between Tomkins and Smith & Wesson Holding Corporation, the Company acquired (the “Acquisition”) all of the issued and outstanding shares of the Smith & Wesson Corp. (“Smith & Wesson”). As a result of the Acquisition, Smith & Wesson became a wholly owned subsidiary of the Company. The Company paid $15,000,000 (the “Purchase Price”) in exchange for all of the issued and outstanding shares of Smith & Wesson as follows:

  •  $5 million (See the “Melby Loan”) of which was paid at closing in cash;
 
  •  $10 million due on or before May 11, 2002 pursuant to the terms of an unsecured promissory note issued by the Company to Tomkins (the “Acquisition Note”). The Acquisition Note accrues interest at a rate of 9% per year; and
 
  •  A receivable of $464,500 due from Tomkins to the Company.

      The Purchase Price was the result of negotiations between the Company and Tomkins. This acquisition has been accounted for under the purchase method pursuant to APB 16, “Business Combinations.” A summary of the net assets acquired is as follows:

           
Acquisition cost:
       
 
Cash paid on May 11, 2001
  $ 5,000,000  
 
Note payable, Tomkins (Acquisition Note)
    10,000,000  
     
 
Total consideration
    15,000,000  
     
 
As of May 11, 2001:
       
 
Cash and cash equivalents acquired
  $ 48,598,168  
 
Accounts receivable
    7,733,517  
 
Inventory
    24,258,858  
 
Collateralized cash deposits
    5,150,000  
 
Other current assets
    1,976,862  
 
Due from Tomkins Corporation
    7,699,500  
 
Property, plant & equipment
    1,582,773  
 
Intangibles
    828,964  
 
Other long-term assets
    13,991,700  
     
 
    $ 111,820,342  
     
 
Liabilities assumed:
       
Accounts payable and accrued expenses
  $ 21,252,449  
Deferred revenue
    1,612,707  
Other non-current liabilities
    23,955,186  
Note payable, Tomkins
    50,000,000  
     
 
      96,820,342  
     
 
Net assets acquired
  $ 15,000,000  
     
 
 
Acquisition Note

      Pursuant to the Acquisition Agreement, the Company issued a promissory note in the amount of $10 million as partial consideration for the acquisition of Smith & Wesson. This note was due on May 11,

16


 

2002, was uncollateralized and bore interest at 9% per annum. During March 2002, the Company obtained a bank loan and paid off the entire balance.
 
Tomkins Note

      The Acquisition Agreement requires the Company to guaranty Smith & Wesson’s existing obligations to Tomkins under a promissory note issued on April 30, 1997 by Smith & Wesson to Tomkins (the “Tomkins Note”). The original Tomkins Note was in the amount of $73,830,000, due April 30, 2004 and bore interest at the rate of 9% per annum. Prior to the Acquisition, Tomkins contributed to the capital of Smith & Wesson, $23,830,000 of the Tomkins Note, thereafter leaving a balance of $50,000,000. Immediately subsequent to the Acquisition, Smith & Wesson paid $20,000,000 of the Tomkins Note. The Company executed a guaranty in favor of Tomkins dated May 11, 2001 and amended the Tomkins Note as follows:

        (a) Commencing on May 11, 2001, the due date was extended by ten years to May 11, 2011;
 
        (b) The unpaid principal balance shall be paid in 84 equal monthly payments commencing on May 11, 2004;
 
        (c) Until May 11, 2006, dividends declared and paid to the Company shall not exceed $600,000 for the twelve month period ended May 11, 2002, and may not exceed $1,800,000 for annual periods thereafter;
 
        (d) Until the payment of $10 million under the Acquisition Note owed by the parent to Tomkins, the Company shall not, either directly or indirectly, incur, assume, guaranty, or otherwise become liable to any indebtedness, except in the ordinary course of business or to re-finance the unpaid balance of the Tomkins Note.
 
        (e) Smith & Wesson shall not liquidate, wind-up or dissolve any business assets, including tangible and intangible assets; and
 
        (f) In the event of default by Smith & Wesson on the Tomkins Note, the Tomkins Note shall be accelerated and become due and payable in full immediately. In addition, any change in control of the Company or Smith & Wesson, will accelerate the Tomkins Note and will become due and payable in full immediately.
 
      The Melby Loan

      The Company obtained financing in the amount of $5 million from an individual, pursuant to a Promissory Note & Loan Agreement dated May 6, 2001 between the Company and this individual (the “Melby Note”). Interest accrued on the Melby Note at a rate of 12% per annum and until maturity on May 15, 2002. During March 2002, the Company obtained a bank loan (See below) and paid off the entire balance. Pursuant to the terms of the Melby Note, the Company prepaid the annual interest of $600,000 at a rate of 12% on May 14, 2001. Related to this loan, the Company also granted warrants, to purchase in aggregate, approximately 8.7 million shares of common stock at exercise prices ranging from $0.40 per share to $2.00 per share.

      As mentioned above, in consideration for making this loan to the Company, the Company issued to Colton Melby, formerly the President and Chief Operating Officer and currently a Director of the Company, a Common Stock Purchase Warrant dated May 6, 2001 (the “Melby Warrant”). The Melby Warrant allowed Mr. Melby to purchase up to 7,094,500 shares of common stock at an exercise price of $.40 per share, subject to adjustment as set forth therein. The Melby warrant was exercisable immediately and would have expired six years from the date of issuance. Also in consideration for the Note, the Company issued Common Stock Purchase Warrants each dated May 11, 2001, to three affiliates of Mr. Melby (the “Affiliate Warrants”). The Affiliate Warrants allowed each holder to purchase up to 300,000 shares of common stock at an exercise price of (a) $.80 per share if exercised on or before May 21, 2001, (b) $2.00 per share if exercised from May 22, 2001 through June 30, 2001, and (c) $5.00 per share if exercised after June 30, 2001. The Affiliate Warrants were exercisable immediately and would have expired one year from the date of issuance. As a portion of a

17


 

finder’s fee for arranging the Melby Note, the Company issued Common Stock Purchase Warrants, each dated May 11, 2001, to two unrelated parties (the “Finders Warrants”). The Finders Warrants would have expired two years from the date of issuance and allowed each holder to purchase up to 354,725 shares of common stock at an exercise price of $1.00 per share. The Company relied upon Section 4(2) of the Securities Act with respect to the issuance of these Warrants.
 
      Bank Loan

      During March 2002, the Company entered into a specific purpose loan agreement with its bank. Pursuant to the terms of this agreement, the Company borrowed $15.0 million to pay the Acquisition Note and the Melby Note related to the acquisition of Smith & Wesson Corp. The outstanding balance of $15.0 million accrues interest at a rate of 5.85% per annum and is collateralized by liquid assets of S&W up to the face aggregate amount of the obligation. Interest is payable monthly and the principal is payable in monthly installments starting April 28, 2004 and is due in full by March 28, 2014. Beginning in April 2004, monthly combined principal and interest payments will be $165,403.

(4) Summary of Significant Accounting Policies:

 
      Principles of Consolidation

      The accompanying consolidated financial statements include the accounts of Smith & Wesson Holding Corporation and its wholly owned subsidiaries — Smith & Wesson Corp., Smith & Wesson Firearms Training Centre GmbH (Germany), Smith & Wesson Distributing, Inc., Smith & Wesson, Inc. and Lost Coast Ventures, Inc. (Inactive). All significant inter-company accounts and transactions have been eliminated in consolidation.

 
      Use of Estimates in Preparation of Financial Statements

      The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Operating results in the future could vary from the amounts derived from management’s estimates and assumptions. In addition, future facts and circumstances could alter management’s estimates with respect to the adequacy of reserves. The more significant estimates and assumptions used by management in the preparation of the financial statements relate to the reserves established for uncollectible accounts receivable, excess and obsolete inventory and certain accrued liabilities, including, but not limited to, product, environmental and warranty liabilities and workers compensation.

 
      Fair Value of Financial Instruments

      Unless otherwise indicated, the fair values of all reported assets and liabilities, which represent financial instruments, none of which are held for trading purposes, approximate the carrying values of such amounts.

 
      Revenue Recognition

      The Company recognizes revenue when the earnings process is complete and the risks and rewards of ownership have transferred to the customer, which is generally upon shipment.

      The Company recognizes tooling, forging, heat treating, finishing, plating, and engineering support revenues after acceptance by the customer and only when no further contingencies or material performance obligations exist, when collectibility is reasonably assured and thereby the Company has earned the right to receive and retain payments for services performed and billed.

      The Company recognizes licensing revenue from the use of its Identi-Kit software over the subscription period.

18


 

      The Company recognizes trademark licensing revenue on a quarterly basis based on actual receipts due from licensees through the date of our financial statements. These revenues are comprised of minimum royalties and/or a percentage of a licensee’s sales on licensed products. Fees received upon initial signing of license agreements are recognized as revenues to the extent of costs incurred. Any amounts in excess of costs are deferred and amortized over the life of the agreement. Due to a combination of uncertain factors regarding existing licensees and past payment performance of licensees in general, the Company believes that reasonable assurance of collectibility does not currently exist. Therefore, the Company does not initially recognize minimum royalty payments, but instead, records such revenue over the period the minimum royalty becomes due and payable. The Company also believes, due to the factors noted above, that an allowance for “uncollectible minimum royalties” cannot reasonably be estimated.

 
      Segment Information

      The Company adopted the provisions of SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information.” SFAS 131 requires public companies to report financial and descriptive information about their reportable operating segments. The Company identifies its operating segments based on how management internally evaluates separate financial information, business activities and management responsibility. At the present time, the Company believes it operates in a single business segment and adoption of this standard did not have a material impact on the Company’s financial statements. For each of the three and six month periods ended October 31, 2002 and 2001, there have been no material foreign operations.

 
      Net Earnings (Loss) Per Share

      Basic earnings per common share are equal to net income divided by the weighted average number of common shares outstanding during the period. Diluted earnings per common share are equal to net income divided by the weighted average number of common shares outstanding during the period, including the effect of stock options and stock awards, if such effect is dilutive.

 
      Stock Options

      As described in Note 8, the Company has stock option plans under which employees and directors have options to purchase Common Stock. The Company applies APB Opinion 25, “Accounting for Stock Issued to Employees” and related interpretations in accounting for its stock option plans. Accordingly, compensation cost is not recognized in the financial statements except in the event where options are granted to consultants at below market exercise prices.

19


 

      The following table illustrates the effect on net income and earnings per share had compensation cost been recognized on the fair value of the options at the grant dates for awards under those plans consistent with Statement of Financial Accounting Standards, No. 123, “Accounting for Stock-Based Compensation” using the Black-Scholes fair value method for option pricing.

                   
For the Six Months Ended
October 31,

2002 2001


Net Income (loss) — as reported
  $ 24,960     $ (11,089,489 )
 
Common stock issued in exchange for services
          281,008  
 
Compensation expense, as determined under the Black Scholes option pricing model
    (541,915 )     (281,008 )
Net Income (loss) — proforma
  $ (516,955 )   $ (11,089,489 )
Basic earnings (loss) per common share:
               
 
Net income (loss) — as reported
  $ (0.00 )   $ (0.57 )
 
Net income (loss) — proforma
  $ (0.02 )   $ (0.57 )
Diluted earnings (loss) per common share:
               
 
Net income (loss) — as reported
  $ (0.00 )   $ (0.57 )
 
Net income (loss) — proforma
  $ (0.02 )   $ (0.57 )
 
      Product Liability

      The Company provides reserves for potential product liability defense costs based on estimates determined in consultation with counsel. Adjustments to the provision for product liability are evaluated on an ongoing basis and are charged or credited to cost of sales. This evaluation is based upon information regarding potential or existing product liability cases. Any future costs as a result of this evaluation are recorded when considered both probable and reasonably estimable.

 
      Environmental Liability

      The Company has provided reserves, on an undiscounted basis for potential environmental obligations that management considers probable and for which reasonable estimates of such obligations can be made. Environmental liabilities are considered probable based upon specific facts and circumstances including, but not limited to, currently available environmental studies, existing technology, presently enacted laws and regulations, the timing of future expenditures, experience in remediation efforts, direction or approval from regulatory agencies, the Company’s status as a potentially responsible party (PRP) and the ability of other PRPs or contractually liable parties, if any, to pay the allocated portion of any environmental obligations. Management believes that the Company has adequately reserved for the reasonable estimable costs of known environmental obligations. Currently, reserves are reviewed and additional reserves or deletions to the reserves may occur due to the specific facts and circumstances previously noted.

                 
Estimated Reserve

Site October 31, 2002 April 30, 2002



Southfield
  $ 1,545,000     $ 1,545,000  
Westfield
    305,000       305,000  
Fire Pond
    1,308,000       1,359,000  
Tank #15
    27,000       27,000  
Wildcat
    108,000       108,000  
Chlorinated Release
    298,000       298,000  
Academy
    444,000       444,000  
     
     
 
Total
  $ 4,035,000     $ 4,086,000  
     
     
 

20


 

 
(5)  Advertising Costs:

      Advertising costs, consisting primarily of magazine advertisements and printed materials, are expensed as incurred. For the six months ended October 31, 2002 and 2001, advertising expenses amounted to approximately $1,820,000 and $986,000, respectively.

(6) Self-Insurance Reserves:

      As of October 31, 2002 and 2001, the Company’s subsidiary, Smith & Wesson, had reserves for workers compensation and product liability totaling $10,337,323 and $12,281,032, respectively, of which, $7,487,323 and $10,556,032, respectively, have been classified as non-current and included in other non-current liabilities and the remaining amounts of $2,850,000 and $1,725,000, respectively, are included in accrued expenses on the accompanying consolidated balance sheet. While management believes these reserves to be adequate, there exists a possibility that the ultimate liabilities will exceed such estimates. Amounts charged to expense were $211,125 and $1,781,724 for the six months ended October 31, 2002 and 2001, respectively.

      Following is a summary of the activity in the workers’ compensation and product liability reserves for the six months ended October 31, 2002 and October 31, 2001:

                 
October 31, 2002 October 31, 2001


Beginning Balance
  $ 11,090,125     $ 12,248,197  
Provision, net of reserve adjustments
    211,125       1,781,724  
Payments
    (963,927 )     (1,748,889 )
     
     
 
Ending balance
  $ 10,337,323     $ 12,281,032  
     
     
 

      It is the Company’s policy to provide an estimate for loss as a result of expected adverse findings or legal settlements where such losses are probable and are reasonably estimable. It is also the Company’s policy to accrue for reasonable estimable legal costs associated with defending such litigation. While such estimates involve a range of possible costs, the Company determines, in consultation with legal counsel, the most likely cost within such range on a case-by-case basis. At October 31, 2002 and October 31, 2001, the Company has product liability reserves of approximately $9.2 million and $10.5 million, respectively comprised entirely of expected legal defense costs.

(7) Commitments and Contingencies:

 
Litigation

      The Company, together with other firearms manufacturers and certain related organizations, is a co-defendant in various legal proceedings involving product liability claims and is aware of other product liability claims including allegations of defective product design, manufacturing, negligent marketing and/or distribution of firearms leading to personal injury(s) including wrongful death. The lawsuits and claims are based principally on the theory of “strict liability” but also may be based on negligence, breach of warranty and other legal theories. In many of the lawsuits, punitive damages, as well as compensatory damages, are demanded. Aggregate claimed amounts presently exceed product liability accruals and, if applicable, insurance coverage. Management believes that, in every case, the allegations of defective product design are unfounded, and that the accident and any results there from were due to negligence or misuse of the firearm by the claimant or a third party and that there should be no recovery against the Company.

      In addition, the Company is also co-defendant in various legal proceedings brought by certain cities, municipalities and counties, against numerous firearms manufacturers, distributors and dealers seeking to recover damages allegedly arising out of the misuse of firearms by third parties in shootings. The complaints by municipalities seek damages, among other things, for the costs of medical care, police and emergency services, public health services, and the maintenance of courts, prisons, and other services. In certain instances, the plaintiffs seek to recover for decreases in property values and loss of business within the city due to increased criminal violence. In addition, nuisance abatement and/or injunctive relief is sought to change the

21


 

design, manufacture, marketing and distribution practices of the various defendants. These suits allege, among other claims, strict liability or negligence in the design of products, public nuisance, negligent entrustment, negligent distribution, deceptive or fraudulent advertising, violation of consumer protection statutes and conspiracy or concert of action theories.

      The Company’s management monitors the status of known claims and the product liability accrual, which includes amounts for defense costs for asserted and unasserted claims. While it is difficult to forecast the outcome of these claims, in the opinion of management, after consultation with litigation counsel, it is uncertain whether the outcome of these claims will have a material adverse effect on the results of operations or financial condition of the Company. Management believes that it has provided adequate reserves for defense costs. The Company does not anticipate a material adverse judgment and intends to vigorously defend itself.

      At this time, the estimated range of reasonably possible additional losses, as that term is defined in SFAS No. 5, is zero. A range of reasonably possible losses relating to unfavorable outcomes cannot be made. However, in the product liability cases in which a dollar amount of damages is claimed, the amount of damages claimed, which totaled approximately $904 million are set forth as an indication of possible maximum liability that the Company might be required to incur in these cases (regardless of the likelihood or reasonable probability of any or all of this amount being awarded to claimants) as a result of adverse judgments that are sustained on appeal.

      In the six months ended October 31, 2002, the Company paid approximately $.8 million in defense and administrative costs relative to product liability and municipal litigation. In addition, the Company spent $197,500 in aggregate in settlement fees relative to product liability cases.

      The Company has recorded the liability for defense costs at a level before reimbursement from insurance carriers. The Company has also recorded the amount due as reimbursement under existing policies from the insurance carriers as a receivable shown in other current assets and other assets.

 
      SEC Investigation

      The SEC is conducting an investigation to determine whether there have been violations of the federal securities laws in connection with matters relating to the restatement of our consolidated financial statements for fiscal year 2002. We continue to be in discussions with the SEC and intend to continue to fully cooperate with the SEC.

 
      Environmental Remediation

      The Company is subject to numerous federal, state and local laws, which regulate the discharge of materials into, or otherwise relate to the protection of, the environment. These laws have required, and are expected to continue to require, the Company to make significant expenditures of both a capital and expense nature. Several of the more significant federal laws applicable to the Company’s operations include the Clean Air Act, the Clean Water Act, the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”) and the Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act (“RCRA”).

      The Company has in place programs and personnel that monitor compliance with various federal, state and local environmental regulations. In the normal course of its manufacturing operations, the Company is subject to occasional governmental proceedings and orders pertaining to waste disposal, air emissions and water discharges into the environment. The Company will fund its environmental costs through cash flows from operating revenue and expects to do so in the future. S&W believes that it is in compliance with applicable environmental regulations in all material respects.

      The Company is required to remediate hazardous waste at Company owned facilities. Currently, it owns designated sites in Springfield, Massachusetts and is subject to five release areas which are the focus of remediation projects as part of the Massachusetts Contingency Plan (MCP). The MCP provides a structured environment for the voluntary remediation of regulated releases. The Company may be required to remove

22


 

hazardous waste or remediate the alleged effects of hazardous substances on the environment associated with past disposal practices at sites not owned by the Company. The Company has received notice that it is a potentially responsible party from the Environmental Protection Agency (EPA) and/or individual states under CERCLA or a state equivalent at one site.

      The Company has reserves of approximately $4.0 million ($3.9 million as non-current) for remediation of the sites referred to above and believes that the time frame for remediation is currently indeterminable. Therefore, the time frame for payment of such remediation is likewise currently indeterminable thus making any net present value calculation irrelevant. The Company’s estimates of these costs are based upon presently enacted laws and regulations, currently available facts, experience in remediation efforts utilizing existing technology, and the ability of other potentially responsible parties or contractually liable parties to pay the allocated portions of any environmental obligations. Where the available information is sufficient to estimate the amount of liability, that estimate has been used; where the information is only sufficient to establish a range of probable liability and no point within the range is more likely than any other, the lower end of the range has been used. The Company does not have insurance coverage for its environmental remediation costs. The Company has not recognized any gains from probable recoveries or other gain contingencies. The environmental reserve was calculated using undiscounted amounts based on independent environmental remediation reports obtained from consultants.

      Based on information known to the Company, management does not expect current environmental regulations or environmental proceedings and claims to have a material adverse effect on the results of operations or financial conditions of the Company. However, it is not possible to predict with certainty the impact on the Company of future environmental compliance requirements or of the cost of resolution of future environmental proceedings and claims, in part because the scope of the remedies that may be required is not certain, liability under federal environmental laws is joint and several in nature, and environmental laws and regulations are subject to modification and changes in interpretation. There can be no assurance that additional or changing environmental regulation will not become more burdensome in the future and that any such development would not have a material adverse effect on the Company.

 
      Contracts

      Employment Agreements — The Company has entered into employment agreements with certain officers and managers to retain their expertise in the ordinary course of business.

      Other Agreements — The Company has various distribution agreements with various third parties in the ordinary course of business.

(8) Stockholders’ Equity:

 
Common Stock

      During the six months ended October 31, 2002 and 2001, warrants were exercised as follows:

        (a) During May 2001, 750,000 warrants were exercised by affiliates of a related party at $0.80 per share for net proceeds of $600,000. These warrants were granted in relation to the financing of the Melby Note (see Note 3).
 
        (b) During August 2001, the Company issued 6,667 shares of the Company’s common shares to a consultant as part of an employment agreement and hence recorded compensation expense of $9,334.
 
        (c) During September 2001, the Company issued 26,667 shares of the Company’s common shares to a consultant for services rendered and hence recorded compensation expense of $37,334.
 
        (d) During September 2001, the Company issued 500,000 shares of the Company’s common shares to one of the finders in relation to the financing of the Melby Note (see Note 2). These shares were issued to settle the finders fee payable at the time the financing was arranged. A total of $185,000 was charged to interest expense as part of the extinguishment of this debt.
 
        (e) During October 2001, the Company issued 87,000 shares of the Company’s common shares to a consultant for services rendered and hence recorded compensation expense of $121,840.

23


 

      The following table provides a reconciliation of the income (loss) amounts and shares used to determine basic and diluted earnings (loss) per share.

                                                 
For the Six Months Ended For the Six Months Ended
October 31, 2002 October 31, 2001


Net Per Share Per Share
Income Shares Amount Net Loss Shares Amount






Basic (loss) per share
  $ 24,960       29,694,556     $ (0.00 )   $ (11,089,489 )     19,613,603     $ (0.57 )
Effect of dilutive stock options
          4,011,024       (0.00 )                  
     
     
     
     
     
     
 
Diluted (loss) per share
  $ 24,960       33,705,580     $ (0.00 )   $ (11,089,489 )     19,613,603     $ (0.57 )
     
     
     
     
     
     
 

      Options and warrants to purchase 300,000 and 19,503,950 shares, respectively, of the Company’s Common Stock were excluded from the October 31, 2002 and 2001 computation of diluted earnings per share because the effect would be antidilutive.

 
      Stock Warrants

      The Company issued warrants related to the financing of debt used for the acquisition of Smith & Wesson Corp., as incentive bonuses to employees and directors, and as compensation to outside consultants during fiscal year 2002.

      In consideration for past services to the Company, including services rendered in connection with the acquisition of Smith & Wesson, the Company issued a Common Stock Purchase Warrant, dated May 11, 2001 (formally approved by the Board of Directors on April 24, 2001), to Mitchell Saltz, former Chief Executive Officer and a director of the Company and a director of Smith & Wesson (the “Saltz Warrant”). The Saltz Warrant entitles Mr. Saltz to purchase up to 5,000,000 shares of common stock at an exercise price of $0.89 per share, subject to adjustment as set forth therein. The Saltz Warrant is exercisable immediately and expires five years from the date of issuance. The Company relied upon Section 4(2) of the Securities Act with respect to the issuance of the Saltz Warrant.

      In consideration for past services to the Company, including services rendered in connection with the acquisition of Smith and Wesson, the Company issued a Common Stock Purchase Warrant, dated May 11, 2001 (formally approved by the Board of Directors on April 24, 2001), to Robert L. Scott, former President and a director of both the Company and Smith & Wesson (the “Scott Warrant”). The Scott Warrant entitles Mr. Scott to purchase up to 5,000,000 shares of common stock at an exercise price of $.89 per share, subject to adjustment as set forth therein. The Scott Warrant is exercisable immediately and expires five years from the date of issuance. The Company relied upon Section 4(2) of the Securities Act with respect to the issuance of the Scott Warrant.

 
      Employee Stock Option and Employee Stock Purchase Plans

      The Company adopted the Employee Stock Option Plan (“the SOP”). The SOP authorizes the issuance of up to 10,000,000 shares of the Company’s common stock pursuant to the exercise of the options granted thereunder. The Board of Directors through its Compensation Committee administers the SOP, selects recipients to whom options are granted and determines the number of shares to be awarded. Options granted under the SOP are exercisable at a price determined by the Committee at the time of grant, but in no event less than fair market value. Grants of options may be made to employees and directors without regard to any performance measures. All options issued pursuant to the SOP are nontransferable and subject to forfeiture. The term of the SOP, unless earlier terminated by the Board, is ten years or May 14, 2011. Any options granted under the SOP shall become exercisable over a period of no longer than ten (10) years. Unless otherwise specified by the Board or the Committee in the resolution authorizing such option, the date of grant of an option shall be deemed to be the date upon which the Board or the Committee authorizes the granting of

24


 

such option. Generally, options vest over a period of three years. In some instances, however, that time period has been reduced. During the six months ended October 31, 2002 and 2001, the Company granted 590,000 and 1,350,000 options,respectively, under the SOP.

      The number and weighted average exercise prices of options granted under the SOP, for the six months ended October 31, 2002 and 2001 are as follows:

                                 
For the Six Months Ended October 31,

2002 2001


Weighted- Weighted-
Average Average
Shares Exercise Price Shares Exercise Price




Options Outstanding, beginning of year
    1,550,000     $ 0.81              
Granted during the period
    590,000     $ 1.29       1,350,000*     $ 0.81  
Exercised during the period
                       
Canceled/forfeited during the period
                       
     
             
         
Options outstanding, end of period
    2,140,000     $ 0.94       1,350,000     $ 0.81  
     
             
         
Shares exercisable, end of quarter
    656,673                        


These options were granted at the close of business on October 31, 2001, therefore no compensation expense under FAS No. 123 has been reflected during the six months ended October 31, 2001.

      A summary of stock options outstanding and exercisable at October 31, 2002 follows:

                                         
Outstanding Exercisable


Number Weighted Average Weighted Number Weighted
Outstanding Remaining Average Exercisable at Average
at October 31 Contractual Life Exercise Price October 31 Exercise Price





Range of Exercise Prices
                                       
$0.81-$0.81
    1,550,000       9.26 years     $ 0.81       516,673     $ 0.81  
$1.18-$1.18
    290,000       9.92 years     $ 1.18       140,000     $ 1.18  
$1.39-$1.39
    300,000       9.98 years     $ 1.39              
     
     
     
     
     
 
$0.81-$1.39
    2,140,000       9.45 years     $ 0.94       656,673     $ 0.89  
     
                     
         

      The Company adopted an Employee Stock Purchase Plan (“the ESPP”), which authorizes the sale of up to 10,000,000 shares of the Company’s common stock to employees and directors. The ESPP commenced operating on June 24, 2002 and shall continue in effect for a term of ten (10) years unless sooner terminated. The ESPP shall be implemented by a series of offering periods of twenty-four (24) months duration, with new offering periods commencing on or about April 1 and October 1 of each year (or at such other time or times as may be determined by the Board of Directors). The purchase price shall be equal to 85% of the fair market value of a share of common stock on the offering date or on the purchase date, whichever is lower. A participant shall elect to have payroll deductions made on each payday during the offering period in an amount not less than one percent (1%) and not more than twenty percent 20% (or such greater percentage as the Board may establish from time to time before an offering date) of such participant’s compensation on each payday during the offering period. The first offering period began on June 24, 2002 and will continue until March 31, 2004. Each offering period shall consist of four (4) consecutive purchase periods of six (6) months’ duration. The last day of each purchase period shall be the purchase date for such purchase period. A purchase period commencing on April 1 shall end on the next September 30. A purchase period commencing on October 1 shall end on the next March 31. The Board of Directors of the Company shall have the power to change the duration and/or the frequency of offering and purchase periods with respect to future offerings and purchases without stockholder approval if such change is announced at least five (5) days prior to the scheduled beginning of the first offering period to be affected. The maximum number of shares an employee may purchase during each purchase period shall be 12,500 shares. All options and rights to participate in the ESPP are nontransferable and subject to forfeiture in accordance with the ESPP guidelines. In the event of

25


 

certain corporate transactions, each option outstanding under the ESPP shall be assumed or an equivalent option shall be substituted by the successor corporation or a parent or Subsidiary of such successor corporation. During the six months ended October 31, 2002 and 2001, 67,117 and 0 shares, respectively, were purchased under the ESPP out of a total authorized of 10,000,000 shares.

      The Company applies APB 25 in accounting for its stock compensation plans, under which no compensation cost has been recognized except in the event where options are granted to consultants at below market exercise prices. The effect on net income and earnings per share had compensation cost been recognized based on the fair value of the options at the grant dates for awards under those plans consistent with Statement of Financial Accounting Standards, No. 123, “Accounting for Stock Based Compensation” using the Black-Scholes fair value method for option pricing is detailed in Note 3 under “Stock Options”.

      For the purpose of computing the pro forma effects of stock compensation under the fair value accounting method, the fair value of each stock option grant or ESPP purchase was estimated on the date of the grant using the Black-Scholes option pricing model. The weighted-average fair value of stock options granted during the six months ended October 31, 2002 and 2001 was $1.11 and $0.72, respectively. The weighted-average fair value of ESPP shares granted during the six months ended October 31, 2002 was $0.59. The following weighted-average assumptions were used for stock option grants and ESPP purchases during the following periods:

                   
Six Months Ended October 31,

2002 2001


Stock option grants:
               
 
Risk-free interest rate
    4.05%       4.26%  
 
Expected life
    8.9 years       9.3 years  
 
Expected volatility
    92.5%       97.0%  
 
Dividend yield
    0%       0%  
Employee Stock Purchase Plan:
               
 
Risk-free interest rate
    3.98%       not applicable  
 
Expected life
    5.3 months       not applicable  
 
Expected volatility
    88.9%       not applicable  
 
Dividend yield
    0%       not applicable  

(9) The Restatement:

 
Overview

      On March 17, 2003, the Company engaged PricewaterhouseCoopers LLP (PwC), as our independent public accountants to audit our financial statements for fiscal year 2003. On August 12, 2003, the Company engaged PwC to conduct a re-audit of our previously issued fiscal year 2002 financial statements. On December 18, 2003, we filed our Form 10-KSB for the fiscal year ended April 30, 2003, which included restated financial statements for the fiscal year ended April 30, 2002. These restatement changes affect the financial statements for each quarter in fiscal years 2003 and 2002. In this Form 10-QSB/ A, we are restating our previously filed financial statements for each of the three month periods and six month periods ended October 31, 2002 and October 31, 2001 to reflect adjustments required with respect to the acquisition balance sheet of Smith & Wesson Corp. (S&W) and other adjustments. These adjustments include, among other items:

  •  adjustments to net sales for product returns and freight invoiced to customers;
 
  •  adjustments to S&W’s product liability and environmental expenses;
 
  •  our accounting for non-cash interest and fees related to a note payable that we issued to finance a part of the acquisition of Smith & Wesson Corp.;

26


 

  •  adjustments to S&W’s income tax accounts; and
 
  •  adjustments to other accounts.
 
Discussion

      The restatement adjustments for fiscal year 2002 and the effects of those adjustments on the three and six months ended October 31, 2002 and 2001 are described within each subsection below:

 
Net Sales and Cost of Sales

      We have restated our fiscal year 2002 financial statements to increase net product sales by $2.8 million and increase cost of sales by $3.8 million. Included in the $2.8 million net product sales increase was $1.2 million to reverse a sales return recorded in error. The sales return related to a pre-acquisition sale by Smith & Wesson Corp., for which no reserve for returns had been established. Accordingly, upon return of the product, we now believe the returned goods should have been recorded as an increase in inventory of $1.2 million and as a reduction to acquired receivables of $1.2 million. As such, we restated our 2002 financial statements to increase net product sales by $1.2 million and increase cost of sales by $1.2 million. We also restated our fiscal year 2002 financial statements to increase net product sales by $1.6 million, increase marketing and selling expense by $0.7 million for cooperative advertising and distributor incentives, increase cost of goods sold by $0.8 million for the cost of freight and $0.1 million used to fund industry programs. These three costs had incorrectly been reported as reductions of sales. We also restated to increase cost of sales by $0.4 million for inventory and equipment write-offs, decrease cost of goods sold by $0.3 million for depreciation expense which was overstated as a result of errors in the S&W purchase accounting and to increase cost of goods sold by $1.6 million for adjustments to product liability reserves.

      The effect of these adjustments on our quarterly financial statements for the three months ended October 31, 2001 is to increase net product sales by $1.6 million which includes the $1.2 million sales return error referenced above and increase cost of sales by $1.1 million for the cost of sales related to the sales return and $0.3 million for the cost of freight. This is partially offset by a product liability adjustment of $0.2 million. We are also restating our financial statements for the three months ended October 31, 2002, to increase net product sales by $0.6 million, increase marketing and selling expense by $0.2 million for cooperative advertising and distributor incentives, $0.2 million of other income/expense, and increase cost of goods sold by $0.3 million for the cost of freight.

      The effect of these adjustments on the six months ended October 31, 2001 is to increase net product sales by $1.9 million, which includes the $1.2 million sales return referenced earlier as well as $0.6 million in freight, promotional and industry dues that had originally been reported as a reduction of sales and should have been charged to cost of sales and operating expenses. Cost of sales has been increased by $2.5 million which includes $1.0 million related to the sales return, $0.8 million relative to the product liability adjustment, $0.3 million in freight costs previously reported as a reduction to sales, and $0.4 million in for inventory and equipment write-offs. For the six months ended October 31, 2002 the effects of the restatement on net product sales was an increase of $1.4 million which, was the freight, promotional and industry dues that had originally been reported as a reduction of sales and should have been charged to cost of sales and operating expenses.

 
Product Liability and Environmental Expenses

      We have restated our fiscal year 2002 financial statements to record additional provisions of $2.5 million for environmental remediation and $1.6 million for product liability and accounted for such amounts as adjustments to the May 11, 2001 acquisition balance sheet of Smith & Wesson Corp. We now believe that under generally accepted accounting principles (GAAP) these amounts, aggregating $4.1 million, should have been expensed in 2002 rather than capitalized as increases to purchased assets under FAS 38, Accounting for Preacquisition Contingencies of Purchased Enterprises, which provides that adjustments of preacquisition contingencies after the end of the allocation period must be included in net income in the period the adjustment is determined. Accordingly, our fiscal year 2002 financial statements were restated to increase cost

27


 

of goods sold by $1.6 million, to increase environmental expense by $2.5 million and to correspondingly reduce the amount of purchase price allocable to reduce purchased fixed assets and intangibles by $4.1 million.

      The effect of these adjustments for the three months ended October 31, 2001, is to decrease cost of goods sold by $0.2 million to adjust the product liability reserve. The effect of these adjustments on the six months ended October 31, 2001 was to increase cost of goods sold by $0.8 million for product liability and to increase environmental expense by $2.5 million.

 
Melby Financing; Interest Expense and Compensation Expense Adjustments

      We determined that there were errors in the accounting for a $5 million debt financing, known as the Melby financing, provided to us by Colton R. Melby to finance part of the acquisition of Smith & Wesson Corp. As a result of this loan and the related stock warrants issued, we originally recorded approximately $5,008,500 in expense consisting of $5,000,000 in interest expense, $6,000 in depreciation expense and $2,500 in office supplies expense in fiscal year 2002. We have now determined that under GAAP we should have recorded aggregate expense of $4,541,500 consisting of $2,567,166 in interest expense for amortization of debt discount related to the warrants; $827,414 in interest expense for amortization of debt issue costs arising from the consideration paid to the parties who assisted in arranging the financing (the finders); a loss on early extinguishment of the note payable of $294,420 charged to interest expense; interest expense of $185,000 resulting from settlement of the finders’ liability and compensation expense of $667,500 to a finder related to his employment by us. The net result of these transactions is that the previously reported pre-tax loss for the fiscal year ended April 30, 2002 was overstated by $467,000. Our fiscal year 2002 financial statements were restated accordingly, to decrease interest expense by $1,126,000, decrease depreciation expense by $6,000, decrease supplies expense by $2,500 and increase general and administrative expense by $667,500 for compensation expense.

      The following discussion provides additional background on the Melby financing. On May 6, 2001, we sold to Mr. Melby a $5 million nonconvertible note due May 12, 2002 and warrants, known as the Melby warrants, to acquire shares of our common stock. At the time of this financing transaction, Mr. Melby had no relationship with us. He became a director of the Company in May 2001, served as our Executive Vice President from May 2002 to September 2002 and served as our President and Chief Operating Officer from September 2002 to December 2003. Under the terms of the Melby financing, we also issued additional warrants, known as the Melby affiliate warrants, to Mr. Melby’s two brothers and one of his associates. Shortly after the issue date, Mr. Melby’s brothers exercised their Melby affiliate warrants. The Melby affiliate warrants issued to Mr. Melby’s associate expired unexercised.

      We initially valued the Melby warrants and the Melby affiliate warrants and recorded a debt discount of $5,000,000 completely offsetting the Melby Note of the same amount. We now believe that under GAAP the $5.0 million financing proceeds should have been allocated among the debt and the Melby warrants and Melby affiliate warrants on a relative fair value basis. Based on their relative values, we have determined that, of the $5.0 million financing proceeds, $2,245,000 should have been allocated to the debt and $2,755,000 should have been allocated to equity for the warrants. As a result of the warrant discount, interest expense for the fiscal year ended April 30, 2002 should have been $2,755,000, comprising $2,567,166 amortized to interest expense over the period from the May 2001 debt issue date through the debt extinguishment date and an early extinguishment loss of $187,834 on the debt extinguishment date. The $5.0 million of debt was redeemed in an early extinguishment on March 28, 2002 for $5 million of consideration consisting of $2,837,000 in cash and $2,162,200 in common stock valued at the March 28, 2002 extinguishment date. Mr. Melby used the $2,837,800 of cash from the extinguishment to exercise his warrants. On the debt extinguishment date, an extinguishment loss of $294,420, including the remaining unamortized debt issue costs of $106,586 and the unamortized debt discount of $187,834, should have been recognized.

      For the three and six months ended October 31, 2001, we should have recorded interest expense of $756,145 and $1,768,809 respectively, relating to the Melby note, the Melby warrants and the Melby affiliate warrants compared to interest expense previously recorded of $1.6 million and $3.6 million, respectively.

28


 

      In connection with the Melby financing, on May 11, 2001 we also issued warrants, known as the finders’ warrants, to the two finders retained to locate the Melby financing. These warrants had a fair value of $434,000. In addition to the finders’ warrants, each finder was also entitled to receive a $250,000 cash fee. On May 6, 2001, we advised the finders that they would be paid this fee in approximately 90 days. We now believe that, under GAAP, we should have recorded debt issue costs of $934,000 together with a corresponding liability of $500,000 and $434,000 of paid in capital for the finders’ warrants. In addition, we should have recorded amortization expense of $827,414 in fiscal year 2002 related to the debt issue costs and we should have written off the remaining unamortized debt issue costs of $106,586 on the debt extinguishment date.

      For the three and six months ended October 31, 2001, we should have recorded interest expense of $236,881 and $480,937 respectively, relating to the finders’ warrants.

      On September 24, 2001, we issued 500,000 shares of common stock to one of the finders to settle the $250,000 liability to him. In addition, on August 9, 2001, we paid $62,500 cash to the other finder, Mr. Corey Lambrecht, which reduced our liability to him from $250,000 to $187,500. On April 1, 2002, Mr. Lambrecht became our Vice President of Licensing. On April 30, 2002, we issued 375,000 shares to him. He has served as our Executive Vice President since September 2002. We had previously recorded the issuance of 875,000 shares of common stock as of May 6, 2001 as a credit to paid in capital for $437,500 or $0.50 per share, although these shares were unissued as of May 6, 2001. We now believe that under GAAP we should have recorded an extinguishment loss of $185,000 in September 2001 based upon the 500,000 shares issued to the first finder on September 24, 2001 (500,000 shares valued at $0.87 as of the date of issuance less the $250,000 restated liability as of May 6, 2001). Based upon the 375,000 shares issued to Mr. Lambrecht on April 30, 2002, our restatement includes a compensation expense of $667,500 in April 2002 (375,000 shares valued at $2.28 on the date of issuance less the $187,500 remaining restated liability as of April 2002).

      Because the finders’ fees were determined to be settled in a fixed number of shares of stock, we now believe that we should have recorded the excess of the market value of the stock to be issued over the original amount of the obligation as additional expense for the three months ended October 31, 2001. The liability to one of the finders was settled during the three months ended October 31, 2001 and $60,000 was recognized as interest expense. The difference between the market value and the initial value of the 500,000 shares due to Mr. Lambrecht for the three months ended October 31, 2001 results in recognizing a decrease in compensation expense of $12,500.

      For the six months ended October 31, 2001, the Company has recorded $185,000 in interest expense as an extinguishment of debt relative to the difference between the market value and the initial value of the 500,000 shares issued to one of the finders. The Company has also recorded $112,500 as compensation expense for the six months ended October 31, 2001 for the difference between the market value and the initial value of the 375,000 shares due to Mr. Lambrecht.

 
Adjustments for Income Tax Accounting Error Corrections

      Our acquisition of Smith & Wesson Corp. was a stock transaction for which no election was made under Internal Revenue Code Section 338 to treat the transaction as an asset purchase for income tax purposes. Therefore, while a new basis of accounting was established for financial reporting purposes, all historical tax bases carried over, resulting in substantial deferred tax temporary differences at the time of the acquisition.

29


 

      On the opening balance sheet at the May 11, 2001 acquisition date of Smith & Wesson Corp., we reported a $10.5 million deferred tax liability. In the fourth quarter of fiscal year 2002, we subsequently determined that this $10.5 million deferred tax liability was an error on the opening balance sheet requiring correction under GAAP. The net deferred tax balance on the opening balance sheet as of May 11, 2001 should have reflected deferred tax liabilities and assets as set forth in the following table.

Deferred Tax Liabilities and Assets Reflected in the Net Deferred Tax Balance

on the Restated Opening Balance Sheet as of May 11, 2001
                           
Previously Reported Restated as of
as of May 11, 2001 Change May 11, 2001



Deferred Tax Liabilities
  $ (10,547,329 )   $ 3,134,816     $ (7,412,513 )
Deferred Tax Assets
    8,000,000       9,648,372       17,648,372  
     
     
     
 
Net Deferred Tax Asset/(Liability) before Valuation Allowance
    (2,547,329 )     12,783,188       10,235,859  
 
Less: Valuation Allowance
    (8,000,000 )     (2,235,859 )     (10,235,859 )
     
     
     
 
Net Deferred Tax Asset/(Liability) at Opening Balance Sheet date
  $ (10,547,329 )   $ 10,547,329     $ 0  
     
     
     
 

      In our previously filed annual report on Form 10-KSB for the fiscal year ended April 30, 2002, we recorded adjustments in the fourth quarter of fiscal year 2002 to correct these errors in the opening balance sheet for deferred tax balances by decreasing net deferred tax liabilities by $10.5 million and decreasing fixed assets and intangible assets by $10.5 million. Although these fourth quarter corrections had no impact on our previously reported tax provision for fiscal year 2002, depreciation and amortization expense for 2002 are overstated as a result of recording the correction in the fourth quarter rather than as of May 11, 2001. We now believe we should have had a net deferred tax asset of $10.2 million with a corresponding valuation allowance of $10.2 million at May 11, 2001 to total to a net zero balance for deferred taxes on the opening balance sheet. This finding has a direct impact on each of the first three quarters of fiscal year 2002 as deferred tax benefits were recorded in each of these quarters.

      The impact for the quarter ended October 31, 2001 was to increase income tax expense by $1.7 million to eliminate the previously reported benefit from income tax of $1.7 million and record income tax expense of $17,649.

      For the six months ended October 31, 2001, the impact was to increase income tax expense by $1.9 million to eliminate the previously reported benefit from income tax of $1.8 million and record income tax expense of $35,298.

 
Other Items

      We also restated our fiscal year 2002 financial statements to record the following adjustments that resulted in the changes set forth in the table above:

  •  Property, Plant and Equipment. — We acquired Smith & Wesson Corp. in a bargain purchase that resulted in writing down long-lived assets below fair value, resulting in decreasing fixed assets to a financial statement basis that is less than the net tax basis, which creates a deferred tax asset. This temporary difference should have resulted in a deferred tax asset of approximately $4.8 million. However, we incorrectly recorded a $2.0 million deferred tax liability related to fixed assets which was included in the $10.5 million deferred tax liability. This error was discovered and corrected in the fourth quarter of fiscal year 2002 but should have been corrected effective May 11, 2001. The adjustment in the fourth quarter of fiscal year 2002 reduced deferred tax liabilities by $2.0 million, increased deferred tax assets by $4.8 million and reduced fixed assets and intangible assets by $6.8 million.

30


 

  •  Trademark. — The trademark is being amortized over a 20-year period for financial statement purposes, and the historical tax basis of the trademark is zero, which results in a deferred tax liability. A deferred tax liability of $2,640,000 relating to the trademark was previously recorded at the opening balance sheet as part of the $10.5 million deferred tax liability. However, Smith & Wesson Corp. had sufficient deferred tax assets to offset this liability, which reverses over a foreseeable time frame (20 years). A full valuation allowance of $8.0 million against deferred tax assets was previously recorded in the opening balance sheet, thus resulting in recognition of only deferred tax liabilities on the balance sheet. In the fourth quarter of fiscal year 2002, we determined that this deferred tax liability must, under GAAP, be considered as a source of future taxable income available to offset deferred tax assets at May 11, 2001. Therefore, at May 11, 2001, no valuation allowance should have been recognized to the extent deferred tax assets will be utilized by this reversing deferred tax liability, meaning that the valuation allowance at opening balance sheet was overstated. This overstatement was corrected in the fourth quarter of 2002.
 
  •  LIFO Reserve. — The last in, first out (LIFO) reserve book versus tax difference was created primarily as the result of purchase accounting adjustments made to inventory. Smith & Wesson Corp. had historically valued its financial statement and tax inventory under the LIFO accounting method. The inventory acquired in the May 11, 2001 acquisition was recorded at fair value. Therefore, for book purposes the LIFO reserve was zero at May 11, 2001. However, the inventory basis and related LIFO reserve was unchanged for tax purposes. Therefore, there was a LIFO reserve for tax purposes only of approximately $14.7 million, creating a temporary difference. We now believe that the use of tax planning strategies available with respect to the LIFO reserve were not appropriately considered for purposes of determining the valuation allowance for the opening balance sheet. This error at opening balance sheet was discovered and corrected in the fourth quarter of the fiscal year 2002 based on tax planning strategies which would allow us to recognize the LIFO temporary difference as a source of future taxable income for purposes of determining the deferred tax asset valuation allowance.
 
  •  Deferred Taxes. — Our Form 10-KSB for the fiscal year ended April 30, 2002 as originally filed also reflects adjustments made in the fourth quarter of fiscal year 2002 to adjust deferred taxes to reverse approximately $2 million of tax benefits recorded over the prior three fiscal quarters.

      We are also filing an amended income tax return with the Internal Revenue Service for the fiscal year ended April 30, 2002. The amended return increases our net operating loss carryforward. As a result, our deferred tax asset relating to net operating losses was also understated in the April 30, 2002 tax provision. Since there is a full valuation allowance against this asset, there is no net balance sheet effect at April 30, 2002 or income statement impact on the financial statements for fiscal year 2002 other than a change to the footnote disclosures.

 
Adjustments to General and Administrative Expenses

      We also restated our fiscal year 2002 financial statements to record $1,232,634 of additional costs and expenses related to reserves for self-insured medical costs, unemployment insurance, workers’ compensation reserves, and legal services that were previously accounted for as purchase adjustments to the May 11, 2001 acquisition balance sheet of Smith & Wesson Corp. and which we now believe under GAAP should have been

31


 

expensed in fiscal year 2002. These adjustments increased our previously reported pre-tax loss for fiscal year 2002. A summary of the items comprising the $1,232,634 is presented below:

Adjustments to Expense in Fiscal Year 2002 for Items Previously Capitalized

         
Increase in medical self insurance reserves and unemployment reserves after the acquisition date
  $ 374,634  
Increase in workers’ compensation reserve and cost of Directors and Officers insurance required under Massachusetts law as a result of the acquisition of Smith & Wesson Corp.
    175,000  
Accounting and legal costs
    683,000  
     
 
Total
  $ 1,232,634  
     
 

      For the three months ended October 31, 2001, we should have recorded a total of $240,000. These expenses are comprised entirely of additional accounting and legal costs.

      For the six months ended October 31, 2001, we should have recorded $450,000 of additional expense consisting of accounting and legal costs of $275,000 and the workers compensation/ Directors and Officers insurance expense of $175,000.

 
Other Income/Expense

      We restated our fiscal year 2002 financial statements to increase other expense by $47,200 which includes a loss on extinguishment of debt $187,834 offset by other income including approximately $61,000 of income from the Walther U.S.A. joint venture.

      For the three months ended October 31, 2001, we should have recorded other income of $331,678 substantially comprised of $55,950 for other income related to the Walther joint venture and interest income of $223,750.

      For the six months ended October 31, 2001, we should have recorded other expense of $21,089.

 
Summary of Restatement Adjustments

      The aggregate impact to our fiscal year statement of operations of the adjustments described above is to increase our previously reported 2002 pre-tax net loss by $5.3 million. The following table summarizes the statement of operations impact of these adjustments on our net loss for the period indicated.

Restatement and Adjustment Impact on Net Income (Loss)

                         
Fiscal Year Ended April 30, 2002

As Previously
Reported Net Change Restated



(In millions, except per share data)
Net Product Sales
  $ 76.5     $ 2.8     $ 79.3  
Cost of Sales
    56.9       (3.8 )     60.7  
License income, net
    1.2       0.0       1.2  
Expenses, including operating expense and other income and expense
    17.7       (5.6 )     23.3  
Interest Expense, net
    8.5       1.3       7.2  
Income Taxes
    0.1       0.0       0.1  
Net income (loss) (increase) decrease
  $ (5.5 )   $ (5.3 )   $ (10.8 )
Earnings per share Basic
  $ (0.27 )   $ (0.25 )   $ (0.52 )
Diluted
  $ (0.27 )   $ (0.25 )   $ (0.52 )

32


 

      The aggregate impact of the fiscal year 2002 restatement on our financial statements for the three months ended October 31, 2001, is to increase our previously reported net loss by $937,373 to $1,363,377. Additionally, the restatement had minor effects on our financial statements for the three months ended October 31, 2002 resulting in a decrease of our net income for that period of $114,746 to $136,862. The following table summarizes the statement of operations impact of these adjustments on our net loss for each of the periods indicated.

Restatement and Adjustment Impact on Net Income (Loss)

                                                 
Three Months Ended Three Months Ended
October 31, 2002 October 31, 2001


As As
Previously Net Previously Net
Reported Change Restated Reported Change Restated






(In millions, except per share data)
Net Product Sales
  $ 23.5     $ 0.6     $ 24.1     $ 19.9     $ 1.6     $ 21.5  
Cost of Sales
    16.6       0.3       16.9       15.8       1.2       17.0  
License income
    0.3       0.0       0.3       0.3       0.1       0.4  
Expenses, including operating expense and other income and expense
    6.3       0.4       6.7       4.1       0.3       4.4  
Interest Expense, net
    0.6       0.1       0.7       2.4       (0.5 )     1.9  
Income Taxes
    0.0       0.0       0.0       (1.7 )     1.7       0.0  
Net Income (loss) (increase) decrease
    0.3       (0.2 )     0.1       (0.4 )     (1.0 )     (1.4 )
 
Earnings per share
                                               
Basic
    .01       (.01 )     0.0       (.02 )     (.05 )     (.07 )
Diluted
    .01       (.01 )     0.0       (.02 )     (.05 )     (.07 )
                                                 
Six Months Ended Six Months Ended
October 31, 2002 October 31, 2001


As As
Previously Net Previously Net
Reported Change Restated Reported Change Restated






(In millions, except per share data)
Net Product Sales
  $ 44.0     $ 1.4     $ 45.4     $ 31.1     $ 1.9     $ 33.0  
Cost of Sales
    31.9       0.4       32.3       26.7       2.5       29.1  
License income, net
    0.6       0.0       0.6       0.6       0.0       0.6  
Expenses, including operating expense and other income and expense
    11.1       0.8       11.9       7.9       3.1       11.0  
Interest Expense
    1.7       0.1       1.8       5.5       (1.1 )     4.5  
Income Taxes
    0.0       0.0       0.0       (1.8 )     1.9       0.0  
Net (loss) (increase) decrease
    0.0 *     0.0 *     0.0       (6.5 )*     (4.5 )     (11.0 )
 
Earnings per share
                                               
Basic
    0.0       0.0       0.0       (.35 )     (.22 )     (.57 )
Diluted
    0.0       0.0       0.0       (.35 )     (.22 )     (.57 )

* Do not add due to rounding

33


 

 
Change from LIFO to FIFO Method

      Our annual report on Form 10-KSB for the fiscal year ended April 30, 2002 incorrectly disclosed that we adopted the first in, first out (FIFO) method of inventory valuation for Smith & Wesson Corp. following our acquisition of Smith & Wesson Corp. on May 11, 2001. We did not adopt the FIFO method of inventory valuation for S&W until the fourth quarter of fiscal year 2002. Our disclosure in our quarterly reports filed on Form 10-QSB for the quarters ended October 31, 2001 and January 31, 2002 correctly disclosed that for these quarters, inventory was valued using the last in, first out (LIFO) method. However, following the acquisition of S&W on May 11, 2001, we failed to record adjustments during each of the first three quarters of fiscal year 2002 to reflect S&W’s inventory in accordance with the LIFO method of inventory accounting. The result was that the cost of sales amounts reported in our previously filed 2002 quarterly financial statements were equivalent to a FIFO basis. S&W changed to the FIFO method of accounting during the fourth quarter of fiscal year 2002.

      Under GAAP, a change to the FIFO method would ordinarily require that the financial statements of all prior periods presented be restated to reflect results under the newly adopted FIFO accounting method. However, since our quarterly results initially reported for the three months ended October 31, 2001 reflect the FIFO basis of accounting for inventory (even though we disclosed that our inventory was accounted for on a LIFO basis) we do not believe we need to amend our previously reported results for this matter.

 
Effect of Restatement on Balance Sheet Items

      The restatement matters described above have the principal effect of reducing property, plant and equipment by approximately $3.5 million, intangible assets by approximately $2.4 million, and equity of the Company by approximately $5.9 million. Also, total liabilities increased by $14.9 million, and assets other than property, plant and equipment and intangible assets increased by $14.9 million.

34


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED BALANCE SHEET — OCTOBER 31, 2002
                             
As Previously
Reported Net Change Restated



ASSETS
Current assets:
                       
 
Cash and cash equivalents
  $ 9,859,651     $ 1,980,827     $ 11,840,478  
 
Marketable securities
    4,729,412       (3,190,522 )     1,538,890  
 
Accounts receivable, net of allowance for doubtful accounts of $114,076
    12,289,596       135,618       12,425,214  
 
Inventories
    18,274,431       (24,001 )     18,250,430  
 
Other current assets
    4,028,959       (563,396 )     3,465,563  
 
Income tax receivable
    198,334       (9,768 )     188,566  
     
     
     
 
   
Total current assets
    49,380,383       (1,671,242 )     47,709,141  
     
     
     
 
Property, plant and equipment, net
    9,123,848       (3,599,823 )     5,524,025  
Intangibles, net
    3,350,676       (2,388,595 )     962,081  
Collateralized cash deposits
    21,000,000       1,209,695       22,209,695  
Other assets
          15,996,000       15,996,000  
     
     
     
 
    $ 82,854,907     $ 9,546,035     $ 92,400,942  
     
     
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
                       
 
Accounts payable
  $ 20,527,886       (15,503,336 )   $ 5,024,550  
 
Accrued expenses
          7,348,734       7,348,734  
 
Accrued payroll
          2,550,271       2,550,271  
 
Accrued taxes other than income
          1,632,967       1,632,967  
 
Accrued profit sharing
          494,137       494,137  
 
Deferred revenue
    1,598,894       (1,332 )     1,597,562  
 
Due to Walther USA, LLC, net
    32,953       171,263       204,216  
     
     
     
 
   
Total current liabilities
    22,159,733       (3,307,296 )     18,852,437  
     
     
     
 
Notes payable
    45,000,000             45,000,000  
     
     
     
 
Other non-current liabilities
    10,735,221       18,854,781       29,590,002  
     
     
     
 
Stockholders’ equity (deficit):
                       
 
Common stock, $.001 par value, 100 million shares authorized, 29,750,730 shares issued and outstanding
    27,620       2,130       29,750  
 
Additional paid-in capital
    16,590,421       (762,961 )     15,827,460  
 
Accumulated (deficit)
    (11,658,088 )     (5,255,792 )     (16,913,880 )
 
Accumulated other comprehensive income
          15,173       15,173  
     
     
     
 
   
Total stockholders’ equity (deficit)
    4,959,953       (6,001,450 )     (1,041,497 )
     
     
     
 
    $ 82,854,907     $ 9,546,035     $ 92,400,942  
     
     
     
 

35


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENT OF OPERATIONS
AND OTHER COMPREHENSIVE INCOME
For the Three Months Ended:
October 31, 2002
                             
As Previously
Reported Net Change Restated



Net sales
  $ 23,470,085     $ 604,646     $ 24,074,731  
License revenue
    371,138       44,990       416,128  
Cost of goods sold
    16,668,328       245,449       16,913,777  
Cost of services
          40,894       40,894  
     
     
     
 
Gross profit
    7,172,895       363,293       7,536,188  
     
     
     
 
Operating expenses:
                       
 
Research and development, net
    106,344       212,373       318,717  
 
Selling and marketing
    2,445,821       264,265       2,710,086  
 
General and administrative
    3,757,357       (94,171 )     3,663,186  
     
     
     
 
   
Total operating expenses
    6,309,522       382,467       6,691,989  
     
     
     
 
Income from operations
    863,373       (19,174 )     844,199  
     
     
     
 
Other income/(expense):
                       
 
Other income
          27,308       27,308  
 
Interest income
    202,160       (27,370 )     174,790  
 
Interest expense
    (800,193 )     (99,888 )     (900,081 )
     
     
     
 
      (598,033 )     (99,950 )     (697,983 )
     
     
     
 
Income before income taxes
    265,340       (119,124 )     146,216  
Income tax expense
    13,732       (4,378 )     9,354  
     
     
     
 
Net income
  $ 251,608     $ (114,746 )   $ 136,862  
Other comprehensive income:
                       
 
Unrealized gain on marketable securities, net of income tax of $5,967
          3,169       3,169  
     
     
     
 
Comprehensive income
  $ 251,608     $ (111,577 )   $ 140,031  
     
     
     
 
Weighted average number of common equivalent shares outstanding, basic
    29,705,499       29,705,499       29,705,499  
     
     
     
 
Net income per share, basic
  $ 0.01     $ (0.01 )   $ 0.00  
     
     
     
 
Weighted average number of common equivalent shares outstanding, diluted
    33,676,970       33,725,708       33,725,708  
     
     
     
 
Net income per share, diluted
  $ 0.01     $ (0.01 )   $ 0.00  
     
     
     
 

36


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENT OF OPERATIONS
AND OTHER COMPREHENSIVE INCOME (LOSS)
For the Six Months Ended:
October 31, 2002
                             
As Previously
Reported Net Change Restated



Net sales
  $ 44,028,847     $ 1,343,232     $ 45,372,079  
License revenue
    646,199       65,677       711,876  
Cost of goods sold
    31,867,602       448,330       32,315,932  
Cost of services
          63,327       63,327  
     
     
     
 
Gross profit
    12,807,444       897,252       13,704,696  
     
     
     
 
Operating expenses:
                       
 
Research and development, net
    301,713       218,561       520,274  
 
Selling and marketing
    4,724,105       594,040       5,318,145  
 
General and administrative
    6,511,198       (74,828 )     6,436,370  
     
     
     
 
   
Total operating expenses
    11,537,016       737,773       12,274,789  
     
     
     
 
Income from operations
    1,270,428       159,479       1,429,907  
     
     
     
 
Other income/(expense):
                       
 
Other income
          54,059       54,059  
 
Interest income
    412,820       (50,257 )     362,563  
 
Interest expense
    (1,697,006 )     (99,888 )     (1,796,894 )
     
     
     
 
      (1,284,186 )     (96,086 )     (1,380,272 )
     
     
     
 
Income/(loss) before income taxes
    (13,758 )     63,393       49,635  
Income tax expense
    20,874       3,801       24,675  
     
     
     
 
Net income/(loss)
  $ (34,632 )   $ 59,592     $ 24,960  
Other comprehensive income:
                       
 
Unrealized gain on marketable securities, net of income tax of $5,967
          12,305       12,305  
     
     
     
 
Comprehensive income/(loss)
  $ (34,632 )   $ 71,897     $ 37,265  
     
     
     
 
Weighted average number of common equivalent shares outstanding, basic
    29,694,556       29,694,556       29,694,556  
     
     
     
 
Net income/(loss) per share, basic
  $ (0.00 )   $ 0.00     $ 0.00  
     
     
     
 
Weighted average number of common equivalent shares outstanding, diluted
    29,694,556       33,705,580       33,705,580  
     
     
     
 
Net income/(loss) per share, diluted
  $ (0.00 )   $ 0.00     $ 0.00  
     
     
     
 

37


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
For the Six Months Ended October 31, 2002
                                                                                                 
As Previously Reported Restated


Accumulated Accumulated
Common Stock Additional Other Total Common Stock Additional Other Total

Paid-in Accumulated Comprehensive Stockholders’
Paid-in Accumulated Comprehensive Stockholders’
Shares Amount Capital Deficit Income Equity Shares Amount Capital Deficit Income Equity












Balance at April 30, 2002
    29,683,613       27,552       16,514,646       (11,623,455 )           4,918,743       29,683,613     $ 29,683     $ 15,751,515     $ (16,938,840 )   $ 2,868     $ (1,154,774 )
Shares issued under ESPP
    67,117       68       75,775                       75,843       67,117       67       75,945                       76,012  
Net income/(loss)for the six month period ended October 31, 2002
                            (34,633 )           (34,633 )                             24,960               24,960  
Other comprehensive income
                                                                              12,305       12,305  
     
     
     
     
     
     
     
     
     
     
     
     
 
Balance at October 31, 2002
    29,750,730     $ 27,620     $ 16,590,421     $ (11,658,088 )   $     $ 4,959,953       29,750,730     $ 29,750     $ 15,827,460     $ (16,913,880 )   $ 15,173     $ (1,041,497 )
     
     
     
     
     
     
     
     
     
     
     
     
 

38


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENT OF CASH FLOWS
For the Six Months ended:
October 31, 2002
                               
As Previously
Reported Net Change Restated



Cash flows (used for) operating activities
                       
 
Net Income/(loss)
  $ (34,632 )   $ 59,592     $ 24,960  
 
Adjustments to reconcile net loss to cash provided by (used for) operating activities:
                       
   
Amortization and depreciation
    544,201       (130,951 )     413,250  
   
Gain on sale of assets
          (2,870 )     (2,870 )
   
Provision for losses on accounts receivable
          15,000       15,000  
   
Provision for excess and obsolete inventory
          197,644       197,644  
 
Changes in operating assets and liabilities (increase) decrease in assets and liabilities
                       
   
Accounts receivable
    (360,831 )     20,053       (340,778 )
   
Inventories
    1,090,644       (183,937 )     906,707  
   
Other current assets
    (1,959,321 )     (59,099 )     (2,018,420 )
   
Income tax receivable
          23,237       23,237  
   
Other assets
          (92,600 )     (92,600 )
 
Increase (decrease) in liabilities:
                       
   
Accounts payable
    (3,520,455 )     1,589,869       (1,930,586 )
   
Accrued payroll
          (584,846 )     (584,846 )
   
Accrued profit sharing
          (325,701 )     (325,701 )
   
Accrued taxes other than income
          (122,892 )     (122,892 )
   
Accrued expenses
          (650,716 )     (650,716 )
   
Other non-current liabilities
          140,227       140,227  
   
Deferred revenue
    1,221       (1,333 )     (112 )
   
Due from Walther USA, LLC, net
          (325,137 )     (325,137 )
     
     
     
 
     
Net cash (used for) operating activities
    (4,239,173 )     (434,460 )     (4,673,633 )
     
     
     
 
Cash flows provided by (used for) provided by investing activities:
                       
 
Payments to acquire marketable securities
          (523,426 )     (523,426 )
 
Proceeds from sale or maturity of marketable securities
    2,809,862       (2,809,862 )      
 
Additions to collateralized cash deposits
          (982,670 )     (982,670 )
 
Payments to acquire patents
    (59,272 )     (7,830 )     (67,102 )
 
Payments to acquire property and equipment
    (2,073,584 )     429,815       (1,643,769 )
     
     
     
 
     
Net cash provided by (used for) provided by investing activities
    677,006       (3,893,973 )     (3,216,967 )
     
     
     
 
Cash flows used for financing activities:
                       
 
Payments on loans and notes payable, related parties
    (357,425 )           (357,425 )
 
Proceeds from exercise of warrants to acquire common stock
    75,842       (75,842 )      
 
Proceeds from sale of common stock
          76,012       76,012  
     
     
     
 
     
Net cash used for financing activities
    (281,583 )     170       (281,413 )
     
     
     
 
Net decrease in cash and cash equivalents
    (3,843,750 )     (4,328,263 )     (8,172,013 )
Cash and cash equivalents, beginning of year
    13,703,401       6,309,090       20,012,491  
     
     
     
 
Cash and cash equivalents, end of period
  $ 9,859,651     $ 1,980,827     $ 11,840,478  
     
     
     
 

39


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED BALANCE SHEET — OCTOBER 31, 2001
                             
As Previously
Reported Net Change Restated



ASSETS
Current assets:
                       
 
Cash and cash equivalents
  $ 34,144,278     $ (6,228,425 )   $ 27,915,853  
 
Accounts receivable, net of allowance for doubtful accounts of $94,812
    10,843,226       62,140       10,905,366  
 
Inventories
    19,145,812       (424,804 )     18,721,008  
 
Other current assets
    4,815,075       (1,601,836 )     3,213,239  
 
Due from Tomkins Corporation
    464,500             464,500  
 
Due from Walther USA, LLC, net
          458,374       458,374  
     
     
     
 
   
Total current assets
    69,412,891       (7,734,551 )     61,678,340  
     
     
     
 
Property, plant and equipment, net
    9,034,250       (6,436,320 )     2,597,930  
Intangibles, net
    4,831,082       (4,065,649 )     765,433  
Collateralized cash deposits
          6,228,425       6,228,425  
Other assets
    5,372       15,486,328       15,491,700  
     
     
     
 
    $ 83,283,595     $ 3,478,233     $ 86,761,828  
     
     
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
                       
 
Accounts payable
  $ 21,105,949       (15,353,720 )   $ 5,752,229  
 
Accrued expenses
          6,795,206       6,795,206  
 
Accrued payroll
          2,351,369       2,351,369  
 
Accrued taxes other than income
          1,518,627       1,518,627  
 
Accrued income taxes
          21,513       21,513  
 
Finders liability
          300,000       300,000  
 
Deferred revenue
    1,623,858       (1,332 )     1,622,526  
 
Note payable, related parties, net of debt issue costs of $1,439,254
    3,600,000       558,171       4,158,171  
 
Note payable, Tomkins
    10,000,000             10,000,000  
     
     
     
 
   
Total current liabilities
    36,329,807       (3,810,166 )     32,519,641  
     
     
     
 
Notes payable
    30,000,000             30,000,000  
     
     
     
 
Deferred Taxes
    8,696,318       (8,696,318 )      
     
     
     
 
Other non-current liabilities
    10,164,911       22,130,282       32,295,193  
     
     
     
 
Stockholders’ equity (deficit):
                       
 
Common stock, $.001 par value, 100 million shares authorized, 19,501,689 shares issued and outstanding
    16,914       2,588       19,502  
 
Additional paid-in capital
    10,181,286       (1,003,680 )     9,177,606  
 
Accumulated (deficit)
    (12,105,641 )     (5,144,473 )     (17,250,114 )
 
Accumulated other comprehensive income
                 
     
     
     
 
   
Total stockholders’ equity (deficit)
    (1,907,441 )     (6,145,565 )     (8,053,006 )
     
     
     
 
    $ 83,283,595     $ 3,478,233     $ 86,761,828  
     
     
     
 

40


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENT OF OPERATIONS AND
OTHER COMPREHENSIVE INCOME
For the Three Months Ended:
October 31, 2001
                             
As Previously
Reported Net Change Restated



Net sales
  $ 19,918,682     $ 1,628,203     $ 21,546,885  
License revenue
    258,817       120,872       379,689  
Cost of goods sold
    15,843,952       1,123,676       16,967,628  
Cost of services
                 
     
     
     
 
Gross profit
    4,333,547       625,399       4,958,946  
     
     
     
 
Operating expenses:
                       
 
Research and development, net
    140,580       1,317       141,897  
 
Selling and marketing
    2,172,935       31,741       2,204,676  
 
General and administrative
    1,758,945       396,120       2,155,065  
     
     
     
 
   
Total operating expenses
    4,072,460       429,178       4,501,638  
     
     
     
 
Income from operations
    261,087       196,221       457,308  
     
     
     
 
Other income/(expense):
                       
 
Other income
          107,928       107,928  
 
Interest income
    214,350       9,400       223,750  
 
Interest expense
    (2,613,667 )     478,953       (2,134,714 )
     
     
     
 
      (2,399,317 )     596,281       (1,803,036 )
     
     
     
 
Loss before income taxes
    (2,138,230 )     792,502       (1,345,728 )
Income tax (benefit) expense
    (1,712,226 )     1,729,875       17,649  
     
     
     
 
Net loss
  $ (426,004 )   $ (937,373 )   $ (1,363,377 )
Other comprehensive income:
                       
 
Unrealized gain (loss) on marketable securities
                 
     
     
     
 
Comprehensive loss
  $ (426,004 )   $ (937,373 )   $ (1,363,377 )
     
     
     
 
Weighted average number of common equivalent shares outstanding, basic
    18,675,942       20,131,178       20,131,178  
     
     
     
 
Net loss per share, basic
  $ (0.02 )   $ (0.05 )   $ (0.07 )
     
     
     
 
Weighted average number of common equivalent shares outstanding, diluted
    18,675,942       20,131,178       20,131,178  
     
     
     
 
Net loss per share, diluted
  $ (0.02 )   $ (0.05 )   $ (0.07 )
     
     
     
 

41


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENT OF OPERATIONS AND
OTHER COMPREHENSIVE INCOME (LOSS)
For the Six Months Ended:
October 31, 2001
                             
As Previously
Reported Net Change Restated



Net product sales
  $ 31,154,751     $ 1,869,885     $ 33,024,636  
License revenue
    620,913       17,593       638,506  
Cost of goods sold
    26,668,435       2,489,393       29,157,828  
Cost of services
          17,593       17,593  
     
     
     
 
Gross profit
    5,107,229       (619,508 )     4,487,721  
     
     
     
 
Operating expenses:
                       
 
Research and development, net
    284,257       5,363       289,620  
 
Selling and marketing
    3,629,106       179,129       3,808,235  
 
General and administrative
    4,479,160       408,579       4,887,739  
 
Environmental expense
          2,500,000       2,500,000  
     
     
     
 
   
Total operating expenses
    8,392,523       3,093,071       11,485,594  
     
     
     
 
(Loss) from operations
    (3,285,294 )     (3,712,579 )     (6,997,873 )
     
     
     
 
Other income/(expense):
                       
 
Other (expense)
          (21,089 )     (21,089 )
 
Interest income
    472,357       14       472,371  
 
Interest expense
    (5,570,603 )     1,063,003       (4,507,600 )
     
     
     
 
      (5,098,246 )     1,041,928       (4,056,318 )
     
     
     
 
(Loss) before income taxes
    (8,383,540 )     (2,670,651 )     (11,054,191 )
Income tax (benefit) expense
    (1,837,226 )     1,872,524       35,298  
     
     
     
 
Net (loss)
  $ (6,546,314 )   $ (4,543,175 )   $ (11,089,489 )
Other comprehensive income:
                 
     
     
     
 
Comprehensive (loss)
  $ (6,546,314 )   $ (4,543,175 )   $ (11,089,489 )
     
     
     
 
Weighted average number of common equivalent shares outstanding, basic
    18,529,192       19,613,603       19,613,603  
     
     
     
 
Net (loss) per share, basic
  $ (0.35 )     (0.22 )   $ (0.57 )
     
     
     
 
Weighted average number of common equivalent shares outstanding, diluted
    18,529,192       19,613,603       19,613,603  
     
     
     
 
Net (loss) per share, diluted
  $ (0.35 )   $ (0.22 )   $ (0.57 )
     
     
     
 

42


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY
For the Six Months Ended October 31, 2001
                                                 
As Previously Reported

Common Stock Additional Accumulated Other Total

Paid-in Accumulated Comprehensive Stockholders’
Shares Amount Capital Deficit Income (Loss) Equity






Balance at April 30, 2001
    17,931,355     $ 15,800     $ 4,187,500     $ (5,559,327 )         $ (1,356,027 )
Issuance of warrants for services related to debt financing
                    5,000,000                       5,000,000  
Common stock issued to settle liabilities
    500,000       500       249,500                       250,000  
Exercise of warrants
    750,000       527       599,473                       600,000  
Issuance of common stock for services
    87,000       87       144,813                       144,900  
Net (loss)for the six month period ended October 31, 2001
                            (6,546,314 )             (6,546,314 )
Other comprehensive income
                                             
     
     
     
     
     
     
 
Balance at October 31, 2001
    19,268,355     $ 16,914     $ 10,181,286     $ (12,105,641 )         $ (1,907,441 )
     
     
     
     
     
     
 

[Additional columns below]

[Continued from above table, first column(s) repeated]

                                                 
Restated

Common Stock Additional Accumulated Other Total

Paid-in Accumulated Comprehensive Stockholders’
Shares Amount Capital Deficit Income (Loss) Equity (Deficit)






Balance at April 30, 2001
    18,131,355     $ 18,131     $ 4,786,469     $ (6,160,625 )         $ (1,356,025 )
Issuance of warrants for services related to debt financing
                    3,189,000                       3,189,000  
Common stock issued to settle liabilities
    500,000       500       434,500                       435,000  
Exercise of warrants
    750,000       750       599,250                       600,000  
Issuance of common stock for services
    120,334       121       168,387                       168,508  
Net (loss)for the six month period ended October 31, 2001
                            (11,089,489 )             (11,089,489 )
Other comprehensive income
                                           
     
     
     
     
     
     
 
Balance at October 31, 2001
    19,501,689     $ 19,502     $ 9,177,606     $ (17,250,114 )         $ (8,053,006 )
     
     
     
     
     
     
 

43


 

SMITH & WESSON HOLDING CORPORATION and Subsidiaries

 
CONSOLIDATED UNAUDITED STATEMENT OF CASH FLOWS
For the Six Months ended:
October 31, 2001
                               
As Previously
Reported Net Change Restated



Cash flows (used for) provided by operating activities
                       
 
Net (loss)
  $ (6,546,314 )   $ (4,543,175 )   $ (11,089,489 )
 
Adjustments to reconcile net loss to cash provided by (used for) operating activities:
                       
   
Amortization and depreciation
    546,549       (378,494 )     168,055  
   
Provision for losses on accounts receivable
          13,950       13,950  
   
Provision for excess and obsolete inventory
          1,634,472       1,634,472  
   
Debt discount amortization to interest expense
          1,882,809       1,882,809  
   
Amortization of debt issue costs to interest expense
          480,937       480,937  
   
Income tax benefit
    (1,819,634 )     1,819,634        
   
Loss on Finder’s liability settled in stock
          185,000       185,000  
   
Stock compensation for services
    110,900       57,608       168,508  
   
Interest expense, including debt issue costs and beneficial conversion feature
    3,600,000       (3,600,000 )      
   
Compensation expense settled in stock
          112,500       112,500  
 
Changes in operating assets and liabilities (increase) decrease in assets and liabilities:
                       
   
Accounts receivable
    (3,105,805 )     (76,090 )     (3,181,895 )
   
Inventories
    5,134,826       (1,209,668 )     3,925,158  
   
Other current assets
    2,651,246       (4,536,607 )     (1,885,361 )
   
Due from Tomkins
          7,235,000       7,235,000  
   
Due from Walther USA, LLC, net
          190,610       190,610  
   
Income tax receivable
                 
   
Other assets
          (1,305,168 )     (1,305,168 )
 
Increase (decrease) in liabilities:
                       
   
Accounts payable
    (1,773,857 )     3,699,791       1,925,934  
   
Accrued payroll
          (1,470,480 )     (1,470,480 )
   
Accrued income taxes
          21,513       21,513  
   
Finders liability
          300,000       300,000  
   
Accrued taxes other than income
          146,677       146,677  
   
Accrued expenses
          (6,131,127 )     (6,131,127 )
   
Other non-current liabilities
          8,340,007       8,340,007  
   
Deferred revenue
    11,152       (1,333 )     9,819  
     
     
     
 
     
Net cash (used for) provided by operating activities
    (1,190,937 )     2,868,366       1,677,429  
     
     
     
 
Cash flows provided by investing activities:
                       
 
Net cash and cash equivalents acquired from business combination
    28,598,168       20,000,000       48,598,168  
 
Cash portion of acquisition
          (5,000,000 )     (5,000,000 )
 
Proceeds from loans receivable and certificate of deposit
    7,385,000       (7,385,000 )      
 
Additions to collateralized cash deposits
          (1,078,425 )     (1,078,425 )
 
Payments to secure financing
          (362,500 )     (362,500 )
 
Payments to acquire property and equipment
    (817,063 )     (270,866 )     (1,087,929 )
     
     
     
 
     
Net cash provided by investing activities
    35,166,105       5,903,209       41,069,314  
     
     
     
 
Cash flows provided by (used for) financing activities:
                       
 
Payments on loans and notes payable, unrelated parties
    (500,000 )           (500,000 )
 
Proceeds from notes payable, related parties
          5,000,000       5,000,000  
 
Payment on notes payable, Tomkins
          (20,000,000 )     (20,000,000 )
 
Proceeds from exercise of warrants to acquire common stock
    600,000             600,000  
     
     
     
 
     
Net cash provided by (used for) financing activities
    100,000       (15,000,000 )     (14,900,000 )
     
     
     
 
Net increase in cash and cash equivalents
    34,075,168       (6,228,425 )     27,846,743  
Cash and cash equivalents, beginning of year
    69,110             69,110  
     
     
     
 
Cash and cash equivalents, end of period
  $ 34,144,278     $ (6,228,425 )   $ 27,915,853  
     
     
     
 

44


 

 
(10)  Subsequent Events:

      On February 25, 2003, S&W sold approximately 85 acres of company-owned property in the City of Springfield, Massachusetts to the Springfield Redevelopment Authority (SRA) for $1,750,000 resulting in a gain of $1,666,132. SRA is a public body politic and corporate created pursuant to Massachusetts General Laws c. 121B. This property is excess land adjacent to the Company’s manufacturing and office facility. The 85 acres has identified soil and groundwater contamination which previously was part of three of S&W’s voluntary remediation projects, specifically the South Field, West Field, and Fire Pond release areas, under the MCP. This property was acquired by SRA as a defined “Brownfield” under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) (s) 101(39). S&W believes that the SRA plans to create a light industrial and other commercial use development park on the property. SRA, with the support of the City of Springfield, has received governmental “Brownfield” grants or loans to facilitate the remediation and development of the property. S&W has entered into certain environmental agreements and other contractual assurances with the SRA associated with the sale which require the SRA to complete remediation. S&W has not revised its environmental reserve but will monitor the progress of the SRA in the remediation and development of the property. Based on SRA’s progress and success in the Brownfield redevelopment of the property, as well as specific approval of remediation by governing authorities, the Company may reduce the environmental reserve. This reduction would have a significant impact on the Company’s earnings for the period in which such reduction is made.

      On December 5, 2003, Messrs. Saltz and Melby resigned respectively as CEO/ Chairman and as President/ COO of the Company and entered into Severance Agreements with the Company. Each of them will continue to serve as members of the Board of Directors. The Severance Agreements provide them with the salary plus certain benefits they were receiving at the time of resignation through December 31, 2004. Also, the Company has agreed to provide them with a secretary and an office at comparable square footage to their existing personal offices and rent per square foot as being paid by the Company in December 2003 for its corporate headquarters office at a location which is not in the same building as the corporate headquarters. Messrs. Saltz and Melby also agreed that at all votes of shareholders of the Company on or before December 31, 2005, they would not directly or indirectly cause or permit any shares beneficially owned by either of them to be voted for any person other than the nominees recommended by the Nominating Committee of the Board of Directors of the Company and nominated by

the Board of Directors in the Company’s proxy statements. The foregoing voting obligations shall not apply if either Mr. Saltz or Mr. Melby is not recommended by the Nominating Committee to be nominated to stand for election to the Board of Directors by the shareholders.

      Effective December 31, 2003, Corey Lambrecht was removed from his duties as Executive Vice President. The Company is presently in discussion with Mr. Lambrecht regarding the terms of his separation.

45


 

SMITH & WESSON CORP. and Subsidiary (the Predecessor)

PREDECESSOR FINANCIAL STATEMENTS (UNAUDITED)

      The financial statements of Smith & Wesson Corp. are presented as of April 28, 2001 and for the thirteen day period ended May 11, 2001. They are presented for Smith & Wesson Corp. (SW) as predecessor to Smith & Wesson Holding Corporation. The Company has previously filed, on Form 8K/ A dated July 30, 2001 Balance Sheet of the predecessor SW as of April 28, 2001 from which the accompanying Balance Sheet has been derived. SW was acquired by the Company on May 11, 2001.

      The Company has previously filed, on Form 10-KSB dated December 18, 2003, the accompanying Consolidated Statements of Operations, Changes in Stockholder’s Equity and Cash Flows (the “Statements”). These Statements have been prepared without audit and have not been reviewed by independent accountants; however, the Company believes that all adjustments, which include only normal recurring adjustments necessary to fairly present SW’s results of operations, changes in stockholder’s equity and cash flows for the thirteen day period, have been included. All significant intercompany transactions have been eliminated.

46


 

SMITH & WESSON CORP and Subsidiary

CONSOLIDATED BALANCE SHEET — April 28, 2001

             
ASSETS
Current assets:
       
 
Cash and cash equivalents
  $ 972,745  
 
Accounts receivable, net of allowance for doubtful accounts of $281,450
    7,912,080  
 
Inventories
    8,696,698  
 
Due from Tomkins
    58,904,233  
 
Other current assets
    1,519,193  
 
Due from Walther USA, LLC, net
    626,343  
     
 
   
Total current assets
    78,631,292  
     
 
Property, plant and equipment, net
    21,957,552  
Intangibles, net
    15,685,000  
Collateralized cash deposits
    5,150,000  
Other assets
    13,991,700  
     
 
    $ 135,415,544  
     
 
LIABILITIES AND STOCKHOLDER’S EQUITY
Current liabilities
       
 
Accounts payable
  $ 6,018,861  
 
Accrued payroll
    2,761,548  
 
Accrued taxes other than income
    1,516,535  
 
Accrued expenses
    9,243,813  
 
Deferred revenue
    1,616,378  
     
 
   
Total current liabilities
    21,157,135  
     
 
Notes payable
    73,830,000  
Deferred tax liability
    3,016,990  
Other non-current liabilities
    24,559,186  
     
 
Stockholders’ equity:
       
 
Common stock, $.01 par value, 800 shares issued and outstanding
    8  
 
Additional paid-in capital
    70,923,721  
 
Accumulated deficit
    (58,070,144 )
 
Other comprehensive loss
    (1,352 )
     
 
   
Total stockholders’ equity
    12,852,233  
     
 
    $ 135,415,544  
     
 

The accompanying notes are an integral part of these consolidated financial statements.

47


 

SMITH & WESSON CORP and Subsidiary

CONSOLIDATED UNAUDITED STATEMENT OF OPERATIONS

For the Thirteen Day Period Ended May 11, 2001:
             
Net sales
  $ 1,965,385  
Cost of goods sold
    1,784,119  
     
 
Gross Profit
    181,266  
     
 
Operating expenses:
       
 
Research and development, net
    49,979  
 
Selling and marketing
    291,110  
 
General and administrative
    280,345  
     
 
   
Total operating expenses
    621,434  
     
 
Loss from operations
    (440,168 )
     
 
Other income/(expense):
       
 
Other income/expense
    (9,812 )
 
Intercompany credits
    399,974  
 
Interest income
    76,240  
 
Interest expense
    (221,490 )
     
 
      244,912  
     
 
Loss before income taxes
    (195,256 )
Income taxes
     
     
 
Net loss
  $ (195,256 )
     
 
Weighed average number of common equivalent shares outstanding, basic
    800  
     
 
Net loss per share, basic
  $ (244.07 )
     
 
Weighted average number of common equivalent shares outstanding, diluted
    800  
     
 
Net loss per share, diluted
  $ (244.07 )
     
 

The accompanying notes are an integral part of these consolidated financial statements.

48


 

SMITH & WESSON CORP and Subsidiary

CONSOLIDATED UNAUDITED STATEMENTS OF CHANGES IN STOCKHOLDER’S EQUITY

For the Thirteen Day Period Ended May 11, 2001
                                         
Common Stock Additional Total

Paid-in Accumulated Stockholder’s
Shares Amount Capital Deficit Equity





Balance at April 28, 2001
    800     $ 8     $ 70,923,721     $ (58,071,496 )   $ 12,852,233  
Capital contributed by parent
                    23,830,000               23,830,000  
Net loss for the period ended May 11, 2001
                            (195,256 )     (195,256 )
     
     
     
     
     
 
Balance at May 11, 2001
    800     $ 8     $ 94,753,721     $ (58,266,752 )   $ 36,486,977  
     
     
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

49


 

SMITH & WESSON CORP and Subsidiary

CONSOLIDATED UNAUDITED STATEMENT OF CASH FLOWS

For the Thirteen Day Period Ended May 11, 2001:
                 
Cash flows used for operating activities:
       
 
Net loss
  $ (195,256 )
 
Adjustments to reconcile net loss to cash used for operating activities:
       
   
Depreciation and amortization
    245,361  
   
Changes in operating assets and liabilities
       
   
(Increase) decrease in assets:
       
     
Accounts receivable
    178,563  
     
Inventories
    (793,232 )
     
Prepaid expenses and other current assets
    168,674  
   
Increase (decrease) in liabilities:
       
     
Accounts payable
    (1,917,515 )
     
Accrued payroll
    (90,104 )
     
Accrued taxes other than income
    (144,585 )
     
Other current liabilities
    (1,014,971 )
     
Deferred income
    (3,671 )
     
 
       
Net cash used for operating activities
    (3,566,736 )
     
 
Cash flows provided by investing activities:
       
 
Proceeds from intercompany loans receivable
    51,204,732  
 
Payments to acquire property and equipment
    (12,573 )
     
 
       
Net cash provided by investing activities
    51,192,159  
     
 
Net increase in cash and cash equivalents
    47,625,423  
Cash and cash equivalents, beginning of the period
    972,745  
     
 
Cash and cash equivalents, end of the period
  $ 48,598,168  
     
 

The accompanying notes are an integral part of these consolidated financial statements.

50


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Thirteen Day Period Ended May 11, 2001

(1) Organization and Business Activity:

 
Organization

      Smith & Wesson Corp. was incorporated under the laws of the State of Delaware on January 13, 1987. Smith & Wesson Corp. has been in business since 1852, during which period, ownership has changed a few times. Prior to incorporation on January 13, 1987, Smith & Wesson Corp. operated as a division of Lear Siegler. On June 9, 1987, Tomkins Corporation (“Tomkins”), a company organized under the laws of the State of Delaware, acquired all the outstanding stock of the Company.

      On May 11, 2001, Saf-T-Hammer Corporation (the “Parent”) purchased all of the outstanding stock of the Smith & Wesson Corp. for $15,000,000 (See Note 12 “Subsequent Events”).

 
Principles of Consolidation

      The accompanying consolidated financial statements include the accounts of Smith & Wesson Corp. and its wholly owned subsidiaries (collectively the “Company”) — Smith & Wesson Firearms Training Centre GmbH (Germany), Smith & Wesson Distributing, Inc., and Smith & Wesson, Inc. All significant inter-company accounts and transactions have been eliminated in consolidation.

 
Business Activity

      The Company manufactures firearms and related products and accessories for sale to registered distributors, sportsmen, collectors, public safety officials and military agencies in the United States, and also sells to distributors throughout the world.

      The Company has two manufacturing facilities (in Springfield, MA and Houlton, ME), both of which are used primarily to manufacture firearms. However, the Company also uses its machine-tooling capabilities at the Springfield facility to manufacture and assemble bicycles, handcuffs, golf club heads, and component parts for various industries.

(2) Summary of Significant Accounting Policies

 
Fiscal Year End

      The Company’s fiscal year ends on the Saturday closest to April 30. The accompanying consolidated financial statements are for the thirteen-day period from April 29, 2001 through May 11, 2001.

 
Cash

      Equivalents — For the purpose of the statement of cash flows, cash equivalents include all highly liquid debt instruments with original maturities of three months or less which are not securing any corporate obligations.

      Concentration — The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts.

 
Use of Estimates in Preparation of Financial Statements

      The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported

51


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Operating results in the future could vary from the amounts derived from management’s estimates and assumptions. In addition, future facts and circumstances could alter management’s estimates with respect to the adequacy of insurance reserves. The more significant estimates and assumptions used by management in the preparation of the financial statements relate to the reserves established for uncollectible accounts receivable, obsolete and slow moving inventory and certain accrued liabilities, including, but not limited to, product, environmental and warranty liabilities and workers compensation.

 
Fair Value of Financial Instruments

      Unless otherwise indicated, the fair values of all reported assets and liabilities, which represent financial instruments, none of which are held for trading purposes, approximate the carrying values of such amounts.

 
Revenue Recognition

      The Company recognizes revenue when the earnings process is complete and the risks and rewards of ownership have transferred to the customer, which is generally upon shipment.

      The Company recognizes tooling, forging, heat treating, finishing, plating, and engineering support revenues after acceptance by the customer and only when no further contingencies or material performance obligations exist, when collectibility is reasonably assured and thereby the company has earned the right to receive and retain payments for services performed and billed.

      The Company recognizes licensing revenue from the use of its Identi-Kit software over the subscription period.

 
Deferred Revenues

      Deferred revenues represent deposits and prepayments from customers for products and services for which the revenue is not yet recognizable, as the risks and rewards of ownership have not yet transferred to the customer. Management expects to have fully earned such revenues within a 12-month period and they will be recognized into revenues at that time.

 
Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed Of

      The Company evaluates the recoverability of long-lived assets, or asset groups, whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. Should such evaluations indicate that the related future undiscounted cash flows are not sufficient to recover the carrying values of the assets, such carrying values would be reduced to fair value and this adjusted carrying value would become the asset’s new cost basis. Fair value is determined primarily using future anticipated cash flows that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset, or asset group, discounted using an interest rate commensurate with the risk involved.

 
Inventories

      Inventories, consisting primarily of finished firearms components, finished firearms and related products and accessories, are valued at the lower of cost or market using the last-in, first-out (LIFO) method. An allowance for potential non-saleable inventory due to excess stock or obsolescence is provided based upon a detailed review of inventory components, past history and expected future usage.

52


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
      Property, Plant and Equipment

      Property, plant and equipment, consisting of land, building, improvements, machinery, equipment, computers, furniture and fixtures, are recorded at cost and are depreciated using the straight-line method over their estimated useful lives. Expenditures for maintenance and repairs are charged to earnings as incurred; additions, renewals and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. A summary of the estimated useful lives is as follows:

     
Description Useful Life


Building and improvements
  10 to 40 years
Machinery and equipment
  2 to 10 years
Furniture and fixtures
  2 to 10 years
Computers and software
  3 to 5 years
 
      Goodwill

      Goodwill arose from the acquisition of the Company by Tomkins in 1987. This acquisition was accounted for under the purchase method of accounting, whereby, the excess of the purchase price paid over the fair value of assets acquired and liabilities assumed was recorded as goodwill in the amount of approximately $68,525,000. This transaction was recorded by the Company pursuant to guidance provided by the Securities and Exchange Commission on SAB Topic 54 — “Push Down Basis of Accounting Required in Certain Limited Circumstances.” Goodwill is being amortized on a straight-line basis over 40 years as determined by management. During the period ended April 28, 2001, management determined that the carrying amount of the net goodwill balance far exceeded the future net undiscounted cash flows expected to be generated, and accordingly, recognized an impairment loss of $29,000,000. Accumulated amortization as of April 28, 2001 amounted to $23,840,000.

 
      Net Loss Per Share

      Basic net loss per share has been calculated based upon the weighted average number of common shares outstanding during the period. Diluted net loss per share has been determined by dividing the net loss by the weighted average number of common shares outstanding plus the dilutive effect of stock options, warrants, and other convertible securities. Basic and diluted net loss per share are the same for the thirteen-day period ended May 11, 2001, as there were no dilutive securities during this period.

 
      Income Taxes

      The Company uses an asset and liability approach for financial accounting and reporting of income taxes. Deferred tax assets and liabilities are determined based on temporary differences between financial reporting and tax basis assets and liabilities and are measured by applying enacted tax rates and laws to taxable years in which differences are expected to be recovered or settled. A valuation allowance was recorded to reduce deferred tax assets to an amount that represents the Company’s best estimate of the amount of such deferred tax assets that are likely to be realized. Further, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 
      Warranty

      The Company generally provides a lifetime warranty to the “original” purchaser of its firearms products. Estimated warranty obligations are provided for in the period in which the related revenue is recognized. The Company quantifies and records an estimate for warranty related costs based on the Company’s actual

53


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

historical claims experience and the current repair costs. Adjustments are made to accruals as warranty claim data and historical experience warrant. Should the Company experience actual claims and repair costs that are higher than the estimated claims and repair costs used to calculate the provision, the Company’s operating results for the period or periods in which such returns or additional costs materialize will be adversely impacted. Warranty expense for the thirteen-day period ended May 11, 2001 amounted to approximately $46,000.

 
      Product Liability

      The Company provides for product liability claims. The provision for product liability claims are charged to cost of sales.

 
      Insurance Reserves

      The Company is “self-insured” (defined as excessive loss re-insurance) through retentions or deductibles for the majority of its workers’ compensation, automobile, general liability, product liability and group health insurance programs. Self-insurance amounts vary up to $2,000,000 per occurrence. Insurance with third parties, some of which is then reinsured through the Parent, is in place for claims in excess of these self-insured amounts. During the thirteen-day period ended May 11, 2001, all of the Company’s insurance was covered under the Tomkins insurance policies. The Company’s liability for estimated premiums and incurred losses are actuarially determined and recorded in the accompanying consolidated financial statements on an undiscounted basis.

(3) Major Customer:

      One customer accounted for approximately 13% of the Company’s net sales for the thirteen-day period ended May 11, 2001. This customer owed the Company approximately $1,065,000 as of April 28, 2001.

(4) International Sales:

      The Company sells its products worldwide. A breakdown of international and export sales, which accounted for approximately 8% of net sales for the thirteen-day period ended May 11, 2001, is as follows:

         
Net Sales by Region

Europe
  $ 4,000  
Asia
    2,000  
Latin America
    85,000  
All others
    60,000  
     
 
Total
  $ 151,000  
     
 

(5) Advertising Costs:

      Advertising costs, consisting primarily of magazine advertisements and printed materials, are expensed as incurred. For the thirteen-day period ended May 11, 2001, advertising expenses amounted to approximately $64,000.

54


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(6) Inventories:

      A summary, stated at lower of cost or market, is as follows:

         
April 28, 2001

Finished goods
  $ 11,728,375  
Finished parts
    8,856,991  
Work in process
    1,185,470  
Raw material
    1,670,186  
     
 
      23,441,022  
LIFO Reserve
    (14,744,324 )
     
 
    $ 8,696,698  
     
 

      The LIFO reserve reflects the difference between stating the inventory at historical FIFO cost and the current LIFO cost. The LIFO reserve decreased by $1 during the thirteen-day period ended May 11, 2001.

(7) Related Party Transactions:

      Loans receivable, Tomkins balances as of April 28, 2001 amounted to $58,904,233, is uncollateralized, due on demand and bears interest at LIBOR minus 1 percent per annum. Immediately prior to the Acquisition on May 11, 2001, Tomkins repaid the entire balance except for $7,699,500, of which $464,500 will be collected within a year and the remaining balance was held as a collateral for (a) open letters of credit on behalf of the Company by Tomkins in the amount of $2,235,000 and (b) a bond for $5,000,000 for the Company’s workers’ compensation fund on behalf of the Company by Tomkins. During May 2001, the Company collected $5,000,000 and expects to collect an additional $2,235,000 in July 2001, upon the expiration of the open letters of credit. The Company paid $20,000,000 of its indebtedness under the Tomkins Note on May 11, 2001 immediately after its acquisition by Saf-T-Hammer Corporation.

      Interest earned from Tomkins during the thirteen-day period ended May 11, 2001 amounted to approximately $76,000.

 
Note Payable, Tomkins

      On April 30, 1997, the Company declared a dividend of $73,830,000 to Tomkins and issued a note payable (“Tomkins Note”) for $73,830,000. The Tomkins Note bears interest at 9% per annum and matures on April 30, 2004. (See Note 12 Subsequent Events).

      Interest expense and payments to Tomkins during the thirteen-day period ended May 11, 2001 amounted to $221,000.

 
Due from Walther USA, LLC

      On April 1, 2000, the Company acquired 50% interest in Walther USA, LLC, a joint venture with Carl Walther GmbH, a German company. Each member contributed $50,000. Walther USA purchases and sells the “Walther” brand handguns worldwide. The Company or its management do not have management control of Walther USA, however, they provide limited procurement and employee support services. Accordingly, this joint venture has been accounted for under the equity method of accounting, whereby, the Company records its share of net income and losses; however, Smith & Wesson Corp. records its share of net income or loss

55


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

consistent with its April 30 year end. The members of Walther USA, LLC have chosen December 31 as it fiscal year end. A summary of the transactions with Walther USA, LLC is as follows:

             
Period Ended
April, 28, 2001

Due from/(to) Walther USA, LLC:
       
 
Beginning balance
  $ 601,677  
 
Plus expenses paid for Walther USA
    402,553  
 
Plus procurement and fees earned
    183,374  
 
Less payments/collections
    (300,557 )
     
 
   
Ending Balance
  $ 887,047  
     
 
Investment in Walther USA, LLC:
       
 
Beginning balance
  $ (201,521 )
 
50% equity in net loss of Walther USA
    (59,183 )
     
 
   
Net investment in Walther USA
  $ (260,704 )
     
 
Net balance due, as presented on the consolidated balance sheet
  $ 626,343  
     
 
 
      Carl Walther, GmbH

      Carl Walther, GmbH buys products from the Company. Neither the Company, nor its management has any control over the management of Carl Walther, GmbH. A summary of transactions with Carl Walther, GmbH is as follows:

           
Period Ended
April 28, 2001

Due from Carl Walther, GmbH (included in accounts receivable on the consolidated balance sheet):
       
 
Beginning balance
  $  
 
Plus sales
    589,955  
 
Less payments
     
     
 
 
Balance at end of year
  $ 589,955  
     
 

(8) Benefit Plans:

 
      Contributory Defined Investment Plan

      The Company offers a contributory defined investment plan covering substantially all employees who have completed at least 6 months of service, as defined. Employees may contribute from 1% to 15% of their annual pay, with Smith & Wesson matching 50% of the first 6% of combined pre and post-tax compensation. The Company contributions are made at the end of the month. The Company did not make a contribution during the thirteen-day period ended May 11, 2001.

 
      Non-contributory Profit Sharing Plan

      The Company also has a non-contributory profit sharing plan. Employees are eligible on May 1 following their completion of a full fiscal year of continuous service. The Company contributes 15% of its net operating profit before interest and taxes, as defined, to the plan each year. The Company did not make a contribution during the thirteen-day period ended May 11, 2001.

56


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
      Post-Retirement Medical Program

      Prior to 1991, the Company offered a program that provided health care to retirees until age 65. The program was terminated in 1991, but employees who had a combined age and years of service equal to 70 as of December 31, 1996 were grandfathered in the program. The grandfather provision provides varying degrees of coverage based upon years of service as of December 31, 1990. There are currently 15 retirees covered by the program and 21 active employees who are grandfathered under the plan. The post retirement medical liability is based upon reports as provided by an independent consultant. The post retirement medical liability as of April 28, 2001 amounted to approximately $506,000, all of which is included in accrued liabilities on the accompanying balance sheet.

      The following table sets forth the Postretirement Medical and Life Plan’s status and amounts recognized in the Company’s Retirement Incentive Program. The financial position at April 28, 2001 is as follows:

           
Actuarial present value of benefit obligation:
       
 
Accumulated benefit obligation, including vested benefits of $94,494
  $ 172,231  
 
Projected benefit obligation for service rendered to date
    333,586  
 
Plan assets
     
     
 
 
Unpaid pension cost
    333,586  
     
 
Balance at April 28, 2001
  $ 505,817  
     
 
Beginning balance, April 30, 2000
  $ 597,227  
Net periodic postretirement benefit cost/(income)
    (50,600 )
Payments during the April 28, 2001
    (40,810 )
     
 
Balance at April 28, 2001
  $ 505,817  
     
 

(9) Self-Insurance Reserves:

      As of April 28, 2001, the Company had reserves for workers compensation and product liability totaling approximately $12,876,000 of which, $9,867,000 has been classified as long-term. While management believes these reserves to be adequate, there exists a possibility that the ultimate liabilities will exceed such estimates.

      The following is a summary of the activity in the workers’ compensation and product liability reserves for the fiscal year ended April 28, 2001:

         
Period Ended
April 28, 2001

Beginning Balance
  $ 8,826,000  
Provision, net of reserve adjustments
    5,363,000  
Payments
    (1,313,000 )
     
 
Ending balance
  $ 12,876,000  
     
 

(10) Income Taxes:

      The Company is included in the consolidated Federal income tax return of Tomkins for the period ended May 11, 2001. Under a tax sharing agreement between the Company and Tomkins, the Company is obligated to pay Tomkins its allocable share of the Tomkins Corporation tax liability, determined as if the Company were filing a separate consolidated income tax return.

57


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      Future tax benefits (deferred tax liabilities) relate to temporary differences on the following:

           
Period Ended
May 11, 2001

Current assets (liabilities):
       
 
Inventories
  $  
 
Compensation and related accruals
     
 
Other accruals
     
Non-current assets (liabilities) — depreciation
    (3,016,990 )
     
 
Net deferred tax asset/ (liabilities)
  $ (3,016,990 )
     
 

(11) Commitments and Contingencies:

 
  Litigation

      The Company, together with other firearms manufacturers and certain related organizations, is a co-defendant in various legal proceedings involving product liability claims and is aware of other product liability claims including allegations of defective product design, manufacturing, negligent marketing and/or distribution of firearms leading to personal injury(s) including wrongful death. The lawsuits and claims are based principally on the theory of “strict liability” but also may be based on negligence, breach of warranty and other legal theories. In may of the lawsuits, punitive damages, as well as compensatory damages, are demanded. Aggregate claimed amounts presently exceed product liability accruals and, if applicable, insurance coverage. Management believes that, in every case, the allegations of defective product design are unfounded, and that the accident and any results therefrom were due to negligence or misuse of the firearm by the claimant or a third party and that there should be no recovery against the Company

      In addition, the Company is also co-defendant in various legal proceeding brought by certain cities, municipalities and counties, against numerous firearms manufacturers, distributors and dealers seeking to recover damages allegedly arising out of the misuse of firearms by third parties in shootings. The complaints by municipalities seek damages, among other things, for the cost of medical care, police and emergency services, public health services, and the maintenance of courts, prisons, and other services. In certain instances, the plaintiffs seek to recover for decreases in property values and loss of business within the city due to increased criminal violence. In addition, nuisance abatement and/or injunctive relief is sought to change the design, manufacture, marketing and distribution practices of the various defendants. These suits allege, among other claims, strict liability or negligence in the design of products, public nuisance, negligent entrustment, negligent distribution, deceptive or fraudulent advertising, violation of consumer protection statues and conspiracy or concert of action theories.

      The Company’s management monitors the status of known claims and the product liability accrual, which includes amounts for asserted and unasserted claims. While it is difficult to forecast the outcome of these claims, in the opinion of management, after consultation with special and corporate counsel, it is not probable and is unlikely that the outcome of these claims will have a material adverse effect on the results of operations or financial condition of the Company, as management believes that it has provided adequate reserves.

 
Environmental Remediation

      The Company is subject to numerous federal, state and local laws which regulate the discharge of materials into, or otherwise relate to the protection of, the environment. These laws have required, and are expected to continue to require, the Company to make significant expenditures of both a capital and expense nature. Several of the more significant federal laws applicable to the Company’s operations include the Clean

58


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Air Act, the Clean Water Act, the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”) and the Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act (“RCRA”).

      The Company has in place programs and personnel that monitor compliance with various federal, state and local environmental regulations. In the normal course of its manufacturing operations, the Company is subject to occasional governmental proceedings and orders pertaining to waste disposal, air emissions and water discharges into the environment. The Company will fund its environmental costs through cash flows from operating revenue and expects to do so in the future. The Company believes that it is in compliance with applicable environmental regulations in all, material respects.

      The Company is required to remediate hazardous waste at Company owned facilities. Currently, a site in Springfield, Massachusetts is subject to four remediation projects as part of the Massachusetts Contingency Plan (MCP). The MCP provides a structured environment for the voluntary remediation of regulated releases. The Company may be required to remove hazardous waste or remediate the alleged effects of hazardous substances on the environment associated with past disposal practices at sites not owned by the Company. The Company has received notice that it is a potentially responsible party from the Environmental Protection Agency (EPA) and/or individual states under CERCLA or a state equivalent.

      The Company has reserves of $1.735 million for remediation of the sites referred to above and other environmental costs in accordance with its policy to record liabilities for environmental expenditures when it is probable that obligations have been incurred and costs can be reasonably estimated. The Company’s estimates of these costs are based upon currently available facts, existing technology, and presently enacted laws and regulations. Where the available information is sufficient to estimate the amount of liability, that estimate has been used; where the information is only sufficient to establish a range of probable liability and no point within the range is more likely than any other, the lower end of the range has been used.

      Based on information known to the Company, management does not expect current environmental regulations or environmental proceedings and claims to have a material adverse effect on the results of operations or financial condition of the Company. However, it is not possible to predict with certainty the impact on the Company of future environmental compliance requirements or of the cost of resolution of future environmental proceedings and claims, in part because the scope of the remedies that may be required is not certain, liability under federal environmental laws is joint and several in nature, and environmental laws and regulations are subject to modification and changes in interpretation. There can be no assurance that environmental regulation will not become more burdensome in the future and that any such development would not have a material adverse effect on the Company.

 
Employment Contracts

      Employment Agreements — the Company has entered into arms length employment agreements with certain officers and managers to retain their expertise in the ordinary course of business.

 
Operating Rental Leases

      The Company leases space for three of its retail stores aggregating an annual commitment of approximately $252,000 over the next two years. Rent expense for the thirteen-day period ended May 11, 2001 amounted to $10,000.

59


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(12) Subsequent Events:

 
The Acquisition

      Pursuant to a Stock Purchase Agreement (the “Acquisition Agreement”) dated as of May 11, 2001 between Tomkins Corporation (“Tomkins”) and Saf-T-Hammer Corporation (“Parent”), Parent acquired (the “Acquisition”) all of the issued and outstanding shares of the Company. As a result of the Acquisition, the Company became a wholly owned subsidiary of Saf-T-Hammer. The Parent paid $15 million (the “Purchase Price”) in exchange for all of the issued and outstanding shares of Smith & Wesson as follows:

  •  $5 million (See the “Loan”) of which was paid at closing
 
  •  $10 million must be paid on or before May 11, 2002 pursuant to the terms of an unsecured promissory note issued by the Parent to Tomkins (the “Acquisition Note”). The Acquisition Note accrues interest at a rate of 9% per year

      The Purchase Price was the result of negotiations between the Parent and Tomkins.

 
Acquisition Note

      Pursuant to the Acquisition Agreement, the Parent issued a promissory note in the amount of $10 million as partial consideration for the acquisition of the Company. This note is due on May 11, 2002, is unsecured but guaranteed by the Parent and bears interest at 9% per annum. In the event of default by the Parent, the interest rate would increase by an additional 2% per annum on the outstanding balance.

 
Tomkins Note

      The Acquisition Agreement requires the Parent to guaranty the Company’s existing obligations to Tomkins under a promissory note issued on April 30, 1997 by the company to Tomkins (the “Tomkins Note”). The original Tomkins Note was in the amount of $73,830,000, due April 30, 2004 and bore interest at the rate of 9% per annum. Prior to the Acquisition, Tomkins contributed to the capital of the Company $23,830,000 of the Tomkins Note, thereafter leaving a balance of $50,000,000. Immediately subsequent to the Acquisition, the Company paid $20,000,000 of the Tomkins Note. The outstanding principal balance on the Tomkins Note is $30 million. In satisfaction of this condition, the Parent executed a guaranty in favor of Tomkins dated May 11, 2001. The terms of the Tomkins Note was amended as follows:

        (a) Commencing on May 11, 2001, the new due date was extended by ten years to May 11, 2011.
 
        (b) Unpaid principal balance shall be paid in 84 equal monthly payments commencing on May 11, 2004.
 
        (c) Until paid in full, dividends declared and paid to the Parent shall not exceed $600,000 for the twelve-month period ended May 11, 2002, and not exceed $1,800,000 for annual periods thereafter.
 
        (d) Until the payment of $10 million under the Acquisition Note owed by the Parent to Tomkins, the Company shall not, either directly or indirectly, incur, assume, guaranty, or otherwise become liable to any indebtedness, except in the ordinary course of business or to re-finance the unpaid balance of the Tomkins Note.
 
        (e) The Company shall not liquidate, wind-up or dissolve any business assets, including tangible and intangible assets.
 
        (f) In the event of default by the Parent on the Acquisition Note, or default by the Company on the Tomkins Note, the Tomkins Note shall be accelerated and become due and payable in full immediately.

60


 

SMITH & WESSON CORP. and Subsidiary

CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

                  The Loan

      The initial payment of $5 million was obtained as a loan from an individual, pursuant to a Promissory Note & Loan Agreement dated May 6, 2001 between the Parent and this individual (the “Note”). Interest accrues on the Note at a rate of 12% per annum and matures on May 15, 2002. Pursuant to the terms of the Note, the Parent prepaid the annual interest of $600,000 on the latter of five business days after the consummation of the Acquisition or May 15, 2001. This prepayment was consented to by Tomkins.

      The Note is secured by a pledge of all of the issued and outstanding stock of the Company, as evidenced by a Stock Pledge Agreement dated and effective as of May 11, 2001 between the Parent and the individual (the “Pledge Agreement”).

61


 

 
Item 2: Management’s Discussion and Analysis or Plan of Operations

      The following discussion and analysis provides information that we believe is relevant to an assessment and understanding of Smith & Wesson Holding Corporations’s results of operations and financial condition. The discussion should be read in conjunction with the consolidated financial statements and the notes thereto. Unless the context otherwise requires, the terms “Company,” “we,” “us” and “our” refer to Smith & Wesson Holding Corporation, Smith & Wesson Corp., and their subsidiaries combined, and the terms “holding company” and “parent company” refer to Smith & Wesson Holding Corporation while the references to “S&W” refer to Smith & Wesson Corp.

Forward Looking Statements

      This report on Form 10-QSB/A contains “forward-looking statements” within the meaning of Sections 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and the Company intends that such forward-looking statements be subject to the safe harbors created thereby. The Company is hereby providing cautionary statements identifying important factors that could cause the Company’s actual results to differ materially from those projected in forward-looking statements of the Company herein. Any statements that express, or involve discussions as to expectations, beliefs, plans, objectives, assumptions, future events or performances (often, but not always through the use of words or phrases such as “will result,” “expects to,” “will continue,” “anticipates,” “plans,” “intends,” “estimated,” “projects,” and “outlook”) are not historical facts and may be forwarding-looking and, accordingly, such statements involve estimates, assumptions and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. Such “forward-looking statements” are subject to risks and uncertainties set forth in the risk factors contained herein as well as in the Company’s Form 10-KSB for the year ended April 30, 2003.

Critical Accounting Policies

 
Principles of Consolidation

      The accompanying consolidated financial statements include the accounts of Smith & Wesson Holding Corporation and its wholly owned subsidiaries — Smith & Wesson Corp., Smith & Wesson Firearms Training Center GmbH (Germany), Smith & Wesson Distributing, Inc., Smith & Wesson, Inc. and Lost Coast Ventures, Inc. (Inactive). All significant inter-company accounts and transactions have been eliminated in consolidation.

 
Use of Estimates in Preparation of Financial Statements

      The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Operating results in the future could vary from the amounts derived from management’s estimates and assumptions. In addition, future facts and circumstances could alter management’s estimates with respect to the adequacy of insurance reserves. The more significant estimates and assumptions used by management in the preparation of the financial statements relate to the reserves established for uncollectible accounts receivable, obsolete and slow moving inventory and certain accrued liabilities, including, but not limited to, product, environmental and warranty liabilities and workers compensation.

 
Revenue Recognition

      The Company recognizes revenue when the earnings process is complete and the risks and rewards of ownership have transferred to the customer, which is generally upon shipment.

      The Company recognizes tooling, forging, heat treating, finishing, plating, and engineering support revenues after acceptance by the customer and only when no further contingencies or material performance

62


 

obligations exist, when collectibility is reasonably assured and the Company has earned the right to receive and retain payments for services performed and billed.

      The Company recognizes revenue from use of its registered trademarks and from licenses to use its Identi-Kit software. Software revenue is recognized over the subscription period.

      Trademark licensing revenues are comprised of (i) initial fees that are collected upon the signing of, or upon meeting certain conditions in, the licensing agreement and (ii) minimum royalties and/or a percentage of a licensee’s sales of licensed products that are collectible over a multi-year period.

      The Company recognizes trademark licensing revenues for all individual licensees on a quarterly basis based on actual receipts due from licensees through the date of our financial statements. These revenues are comprised of minimum royalties and/or a percentage of a licensee’s sales on licensed products. Under the Company’s current licensing agreements, these revenues are payable on a calendar quarter basis. Fees received upon initial signing of license agreements are recognized as revenues to the extent of costs incurred. Due to a combination of uncertain factors regarding existing licensees and insufficient historical experience, the Company believes that reasonable assurance of collectibility does not exist based on the results and past payment performance of licensees in general.

      Therefore, the Company does not initially recognize minimum royalty payments, but instead, records such revenue over the period the minimum royalty becomes due and payable. The Company also believes, due to the factors noted above, that an allowance for “uncollectible minimum royalties” cannot be reasonably estimated.

 
Product Liability

      The Company provides reserves for potential product liability defense costs based on estimates determined in consultation with counsel. Adjustments to the provision for product liability are evaluated on an ongoing basis and are charged or credited to cost of sales. This evaluation is based upon information regarding potential or existing product liability cases. Any future costs as a result of this evaluation are recorded when considered both probable and reasonably estimable. At this time, the estimated range of reasonably possible additional losses, as that term is defined in SFAS No. 5, is zero.

 
Stock Options

      The Company accounts for stock-based employee compensation arrangements in accordance with the provisions of Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” and complies with the disclosure provisions of SFAS 123, “Accounting for Stock-Based Compensation”. Under APB 25, compensation cost is recognized over the vesting period based on the excess, if any, on the date of grant of the fair value of the Company’s shares over the employee’s exercise price. When the exercise price of the employee share options is less than the fair value price of the underlying shares on the grant date, deferred stock compensation is recognized and amortized to expense in accordance with FASB Interpretation No. 28 over the vesting period of the individual options. Accordingly, if the exercise price of the Company’s employee options equals or exceeds the market price of the underlying shares on the date of grant, no compensation expense is recognized. Options or shares awards issued to non-employees or non-employee directors are valued using the fair value method and expensed over the period services are provided.

 
Results of Operations

      During the restatement of our financial statements for the fiscal year ended April 30, 2002, we determined net sales increased by approximately $2.8 million. The increase was due to reclassification of $1.6 million in promotional and freight expenses that were incorrectly netted against sales and should have been charged to operating expenses and cost of sales, respectively. In addition, a credit was incorrectly recorded for returned product in the amount of $1.2 million. Finally, there was approximately $110,000 in merchandise returned for which credits had not been recorded until fiscal year 2003 that should have been recorded in fiscal year 2002. These adjustments, along with others (See Item I — Restatement), impact our

63


 

quarterly financial statements in both fiscal years 2003 and 2002. The impact of these adjustments that affect the three months ended October 31, 2002 and 2001 are discussed below.
 
Net Product Sales

      Net product sales for the three months ended October 31, 2002 were $24,074,731(restated) compared to net product sales of $21,546,885(restated) for the same three months ended October 31, 2001. Net product sales for the six months ended October 31, 2002 were $45,372,079(restated) compared to net product sales of $33,024,636 (restated) for the same three months ended October 31, 2001.

      Net product sales for the three months and six months ended October 31, 2002 increased by approximately $604,646 and $1,343,232, respectively, as a result of the restatement due to $604,646 and $1,232,585, respectively, in promotional and freight expenses that were incorrectly netted against sales and should have been charged to operating expenses and cost of sales, respectively. In addition, a credit was incorrectly issued for product that had been returned in the amount of $110,000. Net product sales for the three and six months ended October 31, 2001 increased by approximately $1,628,203 and $1,869,885, respectively, as a result of the restatement. This increase was due to sales return recorded in error as well as a reclassification of promotional and freight expenses that were incorrectly netted against sales and should have been charged to operating expenses and cost of sales, respectively.

      For the three and six months ended October 31, 2002, firearms sales increased by $1.1 million and $9.7 million, respectively, as domestic sales continued to recover from the effects of the boycott that had taken place in the year prior to acquisition. The Company began the exclusive distribution of Walther products in the United States in January 2002. Sales of Walther products were $2.6 million and $5.2 million, respectively, in the three and six months ended October 31, 2002. The sales increase also resulted from aggressive promotional efforts at the dealer level aimed at re-establishing Smith & Wesson shelf space with many of the dealers that had discontinued carrying S&W product during the boycott period. Total units sold in the three and six months ended October 31, 2002 increased approximately 14.6% and 52.4%, respectively, over the same periods ending October 31, 2001, or approximately 57,000 units as compared to 50,000 units and approximately 109,000 units as compared to 72,000 units, respectively.

 
Net Licensing Revenue

      Net licensing revenues for the three and six months ended October 31, 2002 were $375,234 (restated) and $648,549, respectively, compared to net licensing revenues of $379,689 (restated) and $620,913 for the same periods ended October 31, 2001. Substantially, all of the increase in net licensing revenues growth is attributable to growth in royalties received from existing licensees.

 
Gross Profit

      Gross profit for the three months ended October 31, 2002 was $7,536,188 (restated), representing an increase of $2,577,242 or 52.0% over the gross profit of $4,958,946 (restated) for the three months ended October 31, 2001. Gross profit for the six months ended October 31, 2002 was $13,704,696 (restated), representing an increase of $9,216,975 or 205.4% over the gross profit of $4,487,721(restated) for the six months ended October 31, 2001. Gross profit as a percentage of net sales (“gross profit margin”) for the three months ended October 31, 2002 was 30.8% (restated), compared to the gross profit margin of 22.6% (restated) for the same period ended October 31, 2001. Gross profit as a percentage of net sales (“gross profit margin”) for the six months ended October 31, 2002 was 29.7% (restated), compared to the gross profit margin of 13.3% (restated) for the same period ended October 31, 2001.

      The increase in gross profit margin in the three and six months ended October 31, 2002 was primarily the result of: (i) the increased sales volume as a result of promotional efforts targeted at capturing additional shelf space at the retail level, and (ii) increased production levels to meet the higher demand, without significant cost increases to the manufacturing cost structure. Management believes that increasing the presence of S&W products at the retail level will provide a significant opportunity to strengthen its position within the consumer market, continue revenue growth and allow for improved profit margins on firearm sales.

64


 

 
Research and Development

      The Company incurred $318,717 (restated), net of expense reimbursement from the National Institute of Justice of approximately $318,139, of research and development costs during the three months ended October 31, 2002 as compared to net expenses of $141,897 (restated) during the same three month period ended October 31, 2001, representing an increase of 124.6%. The Company incurred $520,274 (restated), net of expense reimbursement from the National Institute of Justice of approximately $393,803, of research and development costs during the six months ended October 31, 2002 as compared to net expenses of $289,620 (restated) during the same six month period ended October 31, 2001, representing an increase of 79.6%. These costs relate to an ongoing effort by S&W to develop technology to introduce “authorized user only handguns.”

 
Selling, General and Administrative Expenses

      Total selling, general and administrative expenses (SG&A) for the three and six months ended October 31, 2002 were $6,373,272 (restated) or 26.0% and $11,754,515 (restated) or 25.5%, respectively, of net product sales and licensing revenues compared to $4,359,741 (restated) or 19.9% and $8,695,974 (restated) or 25.8%, respectively, of net product sales and licensing revenues for the three and six months ended October 31, 2001.

      During the three months ended October 31, 2002, SG&A incurred by S&W was $5,673,262(restated), or 89.0% of total SG&A and the Company’s corporate SG&A was $700,010 (restated) or 11.0% of total SG&A. S&W SG&A includes, but is not limited to, selling and marketing employee remuneration of $0.9 million, advertising expense of $0.9 million, general and administrative employee remuneration of $1.0 million, and professional fees of $0.3 million. During the six months ended October 31, 2002, SG&A incurred by S&W was $10,563,727 (restated), or 89.9% of total SG&A and the Company’s corporate SG&A was $1,190,788 (restated) or 10.1% of total SG&A. S&W SG&A includes, but is not limited to, selling and marketing employee remuneration of $1.7 million, advertising expense of $1.8 million, general and administrative employee remuneration of $2.0 million, and professional fees of $0.8 million. Corporate SG&A, for the three months ended October 31, 2002, increased $536,010 or 326.8% from the same three month period ended October 31, 2001. Corporate SG&A, for the six months ended October 31, 2002, increased $406,213 or 82.8% from the same six month period ended October 31, 2001. The changes in corporate SG&A are due primarily to increased staffing relative to the licensing and technology units of the business.

 
Environmental Expense

      Environmental expense for the six months ended October 31, 2001 was $2.5 million all of which occurred in the first quarter of fiscal year 2002. (See Part I — Restatement — Product Liability and Environmental Expenses.) This additional expense, all of which is recorded during this first quarter of fiscal year 2002, is shown separately on the October 31, 2001 restated Consolidated Statement of Operations.

 
Other Income/Expense

      Other income, exclusive of interest expense, for the three and six month periods ended October 31, 2002 were $202,098 (restated) and $416,622 (restated), respectively, as compared to other income of $331,678 (restated) and $451,282, respectively, in the same periods ended October 31, 2001.

 
Interest Expense

      Interest expense for the three and six months ended October 31, 2002 was $900,081 and $1,796,894, respectively, as compared to $2,134,714 (restated) and $4,507,600 (restated), respectively, for the same periods in 2001. The decrease in interest expense is attributable to amortization of debt issue costs related to the $5.0 million of the acquisition financing. Also, in March of 2002, we refinanced $15.0 million in acquisition related short-term debt through a commercial bank loan at a rate of 5.85%. The short-term debt had been comprised of two notes: 1) a $5.0 million acquisition loan with an interest rate of 12.0% per annum, and 2) a $10.0 million one-year note payable to the seller with an interest rate of 9.0% per annum.

65


 

      S&W also has a $30.0 million note payable to Tomkins, which also bears an interest rate of 9.0% per annum, and incurred interest expense amounting to approximately $675,000 and $1,350,000 , respectively, during the three and six month periods ended October 31, 2002. The remaining interest expense arose from the commercial bank loan, bank charges for letters of credit and a related party loan. The change in interest expense from the previously reported figure is due to adjustments to non-cash interest expense principally due to the lowest accretion of debt discount as a result of the restatement. (See Part I — Restatement — Melby Financing; Interest Expense and Compensation Expense Adjustments) During the three months ended October 31, 2001, we incurred $993,026 of interest expense for amortization of debt discount and debt issuance costs related to warrants and $60,000 in interest expense for the excess of the market value of the 500,000 shares of stock to be issued over the original amount of the obligation to one of the finders in lieu of his $250,000 finder’s fee.

 
Income Before Income Taxes

      Net income before income taxes decreased $1,491,944 from a loss of $1,345,728 (restated) for the three months ended October 31, 2001 to income of $146,216 for the three months ended October 31, 2002. Net income before income taxes increased $11,103,826 from a loss of $11,054,191 (restated) for the six months ended October 31, 2001 to income of $49,635 for the six months ended October 31, 2002.

 
Income Taxes

      Income tax expense for the three and six months ended October 31, 2002 was $9,354 and $24,675, respectively, as compared to $17,649 and $35,298 (restated) for the same three and six month period ended October 31, 2001, respectively. This provision is a current provision to record state income taxes.

      We currently have significant deferred tax assets resulting from net operating loss carryforwards and other deductible temporary differences, which will reduce taxable income in future periods. As of April 30, 2002, we had a federal and state valuation allowance established against our deferred tax assets equal to the amount deferred tax assets exceeded deferred tax liabilities of $13.4 million (restated) and $1.4 million (restated) respectively. For the three and six month periods ended October 31, 2002 we have recorded valuation allowances to offset first and second quarter income tax benefits from operations to maintain a valuation allowance equal to the amount deferred tax assets exceed deferred tax liabilities.

      SFAS No. 109, “Accounting for Income Taxes”, requires that deferred tax assets be reduced by a valuation allowance, if based on available evidence, it is more likely than not that the deferred tax assets will not be realized and that it is difficult to conclude that a valuation allowance is not needed when there is negative evidence such as cumulative losses in recent years. Therefore, cumulative losses weigh heavily in the overall assessment. Our cumulative losses in recent years represented sufficient negative evidence to require a valuation allowance. Therefore, we have maintained a full valuation allowance against deferred tax assets in excess of deferred tax liabilities as of October 31, 2002. We intend to maintain a valuation allowance until sufficient positive evidence exists to support its reversal. Reversing a valuation allowance could have a significant effect on our future results of operations and financial position.

 
      Net Income/(Loss)

      Net income for the three and six months ended October 31, 2002 were $136,862 and $24,960, respectively, or basic and diluted net income per share of $0.0 and $0.0, respectively, compared to net loss of $1,363,377 or basic and diluted net loss per share of $.07 and $11,089,489 or basic and diluted net loss per share of $.57, respectively, for the same periods in 2001.

 
      Liquidity and Capital Resources

      The Company’s principal ongoing cash requirements are to finance the production of its manufactured products and to fund the following: develop advanced technology products, grow its trademark licensing program, develop its new catalog sales program and meet other working capital requirements. Growth of the licensing program and development of advanced technology products are a primary focus at the holding

66


 

company level which had approximately $4.4 million of investment capital available to it as of October 31, 2002, for these initiatives as well as for its working capital requirements. Manufactured products and other areas of growth are financed by the operations and working capital of S&W.

      The Company is incurring significant legal and accounting costs relating to the restatement of the financial statements for the fiscal year ended April 30, 2002, the restatement of the quarters in fiscal year 2002, the SEC investigation and severance agreements with certain former officers, entered into in December 2003. As a result of these costs, we expect to record significant expenses in the third fiscal quarter of 2004 that will directly affect operating profit and will likely lead to a net loss for the third quarter of fiscal year 2004.

      The Company had cash, cash equivalents and short-term investments of approximately $35.6 million at October 31, 2002. Of this amount, approximately $22.2 million was held as collateral for the line of credit and long-term note with Banknorth, N.A. as described below. A majority of the cash and cash equivalents of the Company are held by S&W. The Company maintains its cash in money market and bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. Smith & Wesson Holding Corporation’s use of cash held by S&W is subject to certain covenants and restrictions imposed by the terms of the S&W acquisition and its lenders. These restrictions include limitations on the use of cash, dividends paid to Smith & Wesson Holding Corporation by S&W and S&W’s ability to incur or guaranty indebtedness.

      The Company utilized approximately $4.7 million (restated) of net cash in operating activities during the six months ended October 31, 2002 compared to cash provided by operating activities of approximately $1.7 million (restated) during the six months ended October 31, 2001. The decrease of net cash in operating activities during the six months ended October 31, 2003 is due substantially to the $7.2 million received from Tomkins Corporation as part of the acquisition during the same period the previous year.

      Net cash utilized by investing activities was approximately $3.2 million (restated) during the six months ended October 31, 2002 compared to cash provided by investing activities of approximately $41.1 million (restated) during the six months ended October 31, 2001. Substantially all of the cash for investing activities in the current period related to the acquisition of marketable securities cash to collateralize outstanding letters of credit and various machinery and equipment.

      Net cash used for financing activities was approximately $.3 million during the six months ended October 31, 2002 compared to approximately $14.9 million (restated) during the six months ended October 31, 2001. All of the cash used for financing activities in the current period relates to payment on the related party note.

      In May 2001, the Company borrowed $5 million from Colton Melby in order to acquire S&W. The loan accrued interest at the rate of 12%. Mr. Melby received warrants to purchase 7,094,500 shares of common stock at $.40 per share and his brothers received warrants to purchase 375,000 shares each at $.80 per share. In March 2002, the loan was repaid and Mr. Melby fully exercised his warrants by using $2,837,800 of the proceeds to fully exercise his warrants and using $2,162,200 of the proceeds to purchase an additional 1,310,424 shares. Mr. Melby’s brothers exercised their warrants in May 2001. Pursuant to the loan agreement with the Company, Mr. Melby received pre-emptive rights with respect to the issuance of new shares of Company stock for a period of six years after repayment of the loan, except with respect to stock issued to employees, directors and consultants. The Company obtained a $15.0 million long-term loan from Banknorth in April 2002, which was used to repay short-term debt related to the S&W acquisition. This note accrues interest at a fixed rate of 5.85% per annum and has a 12-year term commencing on March 28, 2002. The note is amortized over a 10-year period, requires monthly interest-only payments until March 28, 2004, and monthly principal and interest payments of $165,403 thereafter for the life of the loan. The loan is fully collateralized by S&W’s marketable securities, and/or cash. Of the proceeds from the Banknorth note, $5.0 million was used to repay in full the Melby Note.

      The remaining $30.0 million debt relates to an existing obligation by S&W to Tomkins and was guaranteed by the Company as a part of the acquisition agreement. The note accrues interest at a fixed rate of 9.0% per annum and has a term of 10 years commencing on May 11, 2001. It is uncollateralized, may be

67


 

prepaid in part or in whole at any time, and is amortized over a 10-year period. The note requires monthly interest-only payments until May 11, 2004, and monthly principal and interest payments of $482,672 thereafter for the life of the loan. Although the loan is uncollateralized, it does contain covenants restricting Smith & Wesson Holding Corporation use of S&W cash and other assets, limits the amount of dividends that may be paid to Smith & Wesson Holding Corporation by S&W to $1.8 million per year (other than for the year ended April 30, 2002), and requires immediate repayment if there is a change in ownership of S&W or a change in control of Smith & Wesson Holding Corporation. In April 2003 and July 2003, Smith & Wesson Holding Corporation made early repayments of $2 million and $1 million, respectively, to Tomkins to bring the principal balance down from $30.0 million to $27.0 million.

      As of October 31, 2002, the Company had open letters of credit aggregating approximately $5.9 million.

      We believe that our existing sources of liquidity combined with cash generated from our current licensing revenues and dividends received from S&W will be sufficient to meet our anticipated cash requirements needed to manage our advanced technology operations and our licensing program, as well as satisfy operating expense requirements for at least the next 12 months. Beyond this time period, growth plans and related operating expenses at the holding company level may require revenue generation from advanced technology products or other sources or revenue growth from the licensing subsidiary to meet its anticipated future expenses and debt service requirements. In order to meet these potential future needs, the Company may be required to seek additional equity or debt financing and/or debt refinancing. The timing and amount of any such financing requirements will depend on a number of factors, including demand for our products, changes in industry conditions, new product acceptance and competitive factors. There can be no assurance that such financing will be available on acceptable terms if required, and any additional equity financing would result in incremental ownership dilution to our existing shareholders. Based upon its cash position at fiscal year end and its financial projections for the upcoming year, S&W believes that it has adequate sources of liquidity to meet debt obligations, pay the annual dividend to the parent, and finance operational and capital requirements for at least the next 12 months.

      Various legal actions, proceedings and claims have been instituted against the Company’s subsidiary, S&W. (For further discussion of litigation and legal proceedings pending against the Company and its subsidiary, see Part II — Item 1 — Legal Proceedings; and Note 7 to the Consolidated Financial Statements for Smith & Wesson Holding Corporation and Subsidiaries.) Management believes that, in every case, the allegations are unfounded, defenses exist, and that there should be no recovery against S&W. Legislation has been passed in approximately 30 states precluding suits of the type brought by municipalities. Some of these laws are effective retroactively while others are not.

      The Company’s management reviews every lawsuit and claim at the outset and is in contact with its special litigation counsel on an ongoing basis. The provision for product liability claims is based upon many factors, which vary for each case. These factors include the type of claim, nature and extent of injuries, historical settlement ranges, jurisdiction where filed, and advice of counsel. An accrual is established for each lawsuit and claim, when appropriate, based on the nature of each such lawsuit or claim. If at such time management determines that a claim is reasonably possible and the amount of such claim estimable, an accrual is made. Although reserves have been established for estimable legal defense costs, management believes that the cases are without merit and as such has not provided reserves for settlements or judgments.

      Amounts are charged to product liability expense in the period in which the Company becomes aware that a claim or, in some instances a threat of claim, has been made when potential losses or costs of defense can be reasonably estimated. Such amounts are determined based on the Company’s experience in defending similar claims. On a quarterly basis the cases are reviewed with outside counsel, and if necessary, reserves are adjusted accordingly based upon individual case developments. During the three months ended October 31, 2002 and October 31, 2001, the Company incurred product liability expense of approximately $216,000 and a credit of $46,000, respectively. During the six months ended October 31, 2002 and October 31, 2001, the Company incurred product liability expense of approximately $74,000 and $1,000,000, respectively.

      Since it is not possible to forecast the outcome of litigation or the timing of costs, in the opinion of management, after consultation with its litigation counsel, it is uncertain whether any ongoing litigation,

68


 

including punitive damage claims, will have a material adverse effect on the financial position of the Company or a material impact on the Company’s financial results for a particular period.

      The Company is subject to numerous federal, state and local laws, which regulate or otherwise relate to the protection of the environment. The Company may be required to remove hazardous waste or remediate the alleged effects of hazardous substances on the environment associated with past operations or disposal practices. As of October 31, 2002, the Company has reserves of approximately $4.0 million for environmental matters. The amount of the Company’s liabilities for remedial environmental activities are very difficult to estimate due to such factors as currently available facts, remediation technology, enacted laws or regulations and the unknown extent of the remedial actions that may be required.

      The Company has identified environmental issues on the property at the Springfield, Massachusetts facility. The Company has a voluntary remediation project underway as part of the Massachusetts Contingency Plan (MCP). The Company has established reserves to cover the cost of this remediation project and believes these reserves to be adequate.

      The Company also has a potential environmental issue at its ranges at the training facility in Springfield, Massachusetts. This site may require remediation if the Company were to decide to cease using this facility as a shooting range. The Company has no plans to discontinue use of its training facility.

Risk Factors

      In addition to the other information contained in this quarterly report, the reader should carefully read and consider the following risk factors. If any of these risks actually occur, our business, financial condition or operating results could be adversely affected and the trading price of our common stock could decline.

  •  We are under investigation by the SEC to determine whether there have been violations of the federal securities laws in connection with matters relating to the restatement of our consolidated financial statements for fiscal year 2002. While we have fully cooperated with the SEC and intend to continue to do so, we cannot predict what the outcome of the investigation will be or when it will be completed. If the SEC determines that we have violated federal securities laws, we may face sanctions, including, but not limited to, significant monetary penalties and injunctive relief.
 
  •  Our management has spent considerable time and effort dealing with internal and external investigations of our controls and procedures, and this diversion of management’s time may adversely affect our business and our results of operations.
 
  •  We have made, and continue to make, changes to our internal controls, our disclosure controls and procedures, our internal control over financial reporting and our corporate governance policies and procedures. Any design, operating maintenance or evaluation failure or circumvention of these controls and procedures could seriously harm our business.
 
  •  If we fail to satisfy our plan for our return to compliance with the American Stock Exchange’s continued listing standards, our stock will likely be delisted. If our stock is delisted, our stock could become more difficult to trade and our ability to raise funds in the capital markets may be impaired, which could have a material adverse effect on our business.
 
  •  We are incurring significant legal and accounting costs relating to the restatement of our financial statements for the fiscal year ended April 30, 2002, the SEC investigation and recently approved severance arrangements with former officers that will directly affect our operating profit and will likely lead to a net loss for the third quarter of fiscal year 2004.
 
  •  We are subject to sales cycles driven by national events (such as 9/11/2001) which can cause dramatic increases or decreases in demand for our products and we have no ability to predict or control those cycles.
 
  •  We are defending many lawsuits brought by various cities and counties arising out of the design, manufacture, marketing and distribution of our handguns. While we are vigorously defending these

69


 

  lawsuits and believe they are without merit and further believe our insurance is adequate in light of judgments entered against the industry to date, there is no assurance that a jury may not render a judgment against us in excess of insurance coverage limits.
 
  •  If forced to comply with a settlement with HUD restricting our design, manufacturing, marketing and distribution of firearm products, we could be substantially impaired from competing with manufacturers who sell competing products. We believe the HUD Settlement is not legally binding, and have received confirmation that the HUD Settlement will not be enforced, but can provide no assurance that a court would not rule otherwise, as the HUD Settlement has not been formally rescinded.
 
  •  We have substantial repayment obligations related to the purchase of our wholly-owned subsidiary, Smith & Wesson Corp. for which we are developing a viable sales model to generate sufficient cash flow to make the payments required. Various covenants prohibit us from making payments directly from our subsidiary, Smith & Wesson Corp. We must begin to repay the principal on one of our loans in April 2004.
 
  •  We are expanding our technology, licensing and catalog operations. All of these areas are highly competitive and subject to changes in demand.
 
  •  Our two significant notes contain covenants and the preemptive rights held by Colt Melby could limit our discretion with respect to various business matters.
 
  •  Cost of insurance for all firearms manufacturers continue to increase and we have been impacted by those increases.
 
  •  We continue our efforts to overcome adverse publicity from past settlement agreements.
 
  •  Some of our competitors’ cost structures may be more advantageous than ours.
 
  •  We operate in a highly regulated business at the international, national, state and local levels and there is no assurance that regulation may not increase having a material adverse effect on our business, including not only regulation related to firearm production itself but also related to environmental laws in a manufacturing context in general.
 
  •  We are currently engaged in remedial investigation and cleanup activities at certain sites and cannot be sure that we have identified all existing contamination or will not cause contamination in the future, making our reserves of approximately $4.0 million inadequate.
 
  •  We depend on outside suppliers and vendors for our raw materials and other supplies.
 
  •  Demand for our products is subject to the popularity of our product line, acceptance of new product designs, ongoing quality control and adequate supply of Walther products from our German supplier.
 
  •  We are exposed to currency risk from foreign exchange rate fluctuations in connection with inventory we purchase from a European supplier. If the U.S. dollar continues to weaken and our hedging arrangements do not provide adequate protection, we could experience additional expenses on inventory we purchase annually from the European supplier.

70


 

PART II:     OTHER INFORMATION

 
Item 6. Exhibits and Reports on Form 8-K

  (a)  Exhibits:
         
    31.1   Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer
    31.2   Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer
    32.1   Section 1350 Certification of Principal Executive Officer
    32.2   Section 1350 Certification of Principal Financial Officer

  (b)  Reports on Form 8-K:

None

71


 

SIGNATURES

      In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  SMITH & WESSON HOLDING CORPORATION,
  a Nevada corporation

  By:  /s/ ROY C. CUNY
 
  Roy C. Cuny,
  Chief Executive Officer and Chairman of the Board

Dated: January 9, 2004

72


 

Index to Exhibits

         
    31.1   Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer
    31.2   Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer
    32.1   Section 1350 Certification of Principal Executive Officer
    32.2   Section 1350 Certification of Principal Financial Officer
exv31w1
 

Exhibit 31.1

CERTIFICATION

I, Roy C. Cuny, Chief Executive Officer, certify that:

      1.     I have reviewed this quarterly report on Form 10-QSB/ A of Smith & Wesson Holding Corporation;

      2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

      3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

      4.     The small business issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

        (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
        (b) Evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
        (c) Disclosed in this report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s most recent fiscal quarter (the small business issuer’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over financial reporting; and

      5.     The small business issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors (or persons performing the equivalent functions):

        (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize and report financial information; and
 
        (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer’s internal control over financial reporting.

  By:  /s/ ROY C. CUNY
 
  Roy C. Cuny
  Chief Executive Officer

Date: January 9, 2004

exv31w2
 

Exhibit 31.2

CERTIFICATION

I, Damian A. Larson, Chief Financial Officer, certify that:

      1.     I have reviewed this quarterly report on Form 10-QSB/ A of Smith & Wesson Holding Corporation;

      2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

      3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

      4.     The small business issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

        (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
        (b) Evaluated the effectiveness of the small business issuer’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
        (c) Disclosed in this report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s most recent fiscal quarter (the small business issuer’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over financial reporting; and

      5.     The small business issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer’s auditors and the audit committee of the small business issuer’s board of directors (or persons performing the equivalent functions):

        (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer’s ability to record, process, summarize and report financial information; and
 
        (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer’s internal control over financial reporting.

  By:  /s/ DAMIAN A. LARSON
 
  Damian A. Larson
  Chief Financial Officer

Date: January 9, 2004

exv32w1
 

Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      Pursuant to 18 U.S.C. (s) 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Smith & Wesson Holding Corporation (the “Company”) hereby certifies, to such officer’s knowledge, that:

        (i) the accompanying Quarterly Report on Form 10-QSB/ A of the Company for the fiscal quarter ended October 31, 2002 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
 
        (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  By:  /s/ ROY C. CUNY
 
  Roy C. Cuny
  Chief Executive Officer

Dated: January 9, 2004

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. (s) 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

exv32w2
 

Exhibit 32.2

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      Pursuant to 18 U.S.C. (s) 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Smith & Wesson Holding Corporation (the “Company”) hereby certifies, to such officer’s knowledge, that:

        (i) the accompanying Quarterly Report on Form 10-QSB/ A of the Company for the fiscal quarter ended October 31, 2002 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
 
        (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  By:  /s/ DAMIAN A. LARSON
 
  Damian A. Larson
  Chief Financial Officer

January 9, 2004

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. (s) 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.